PC3
MCID: PCH010
MIFTS: 44

Pachyonychia Congenita 3 (PC3)

Categories: Fetal diseases, Genetic diseases, Oral diseases, Rare diseases, Skin diseases

Aliases & Classifications for Pachyonychia Congenita 3

MalaCards integrated aliases for Pachyonychia Congenita 3:

Name: Pachyonychia Congenita 3 56 73 29 6 71
Pc3 56 73
Pachyonychia Congenita, Type 3 39
Pc-3 17

Characteristics:

OMIM:

56
Inheritance:
autosomal dominant


Classifications:



Summaries for Pachyonychia Congenita 3

OMIM : 56 Pachyonychia congenita (PC) is an autosomal dominant genodermatosis with the main clinical features of hypertrophic nail dystrophy, painful and highly debilitating plantar keratoderma, oral leukokeratosis, and a variety of epidermal cysts. Although the condition had previously been subdivided clinically into Jadassohn-Lewandowsky PC type 1 and Jackson-Lawler PC type 2, patients with PC were later found to have a mixed constellation of both types, leading to a classification of PC based on genotype (summary by Sybert, 2010; Eliason et al., 2012; McLean et al., 2011). For a discussion of genetic heterogeneity of pachyonychia congenita, see 167200. (615726)

MalaCards based summary : Pachyonychia Congenita 3, also known as pc3, is related to prostate cancer and suppression of tumorigenicity 12. An important gene associated with Pachyonychia Congenita 3 is KRT6A (Keratin 6A). The drugs Remifentanil and Narcotics have been mentioned in the context of this disorder. Affiliated tissues include prostate, bone and breast, and related phenotypes are hyperhidrosis and palmoplantar keratoderma

UniProtKB/Swiss-Prot : 73 Pachyonychia congenita 3: An autosomal dominant genodermatosis characterized by hypertrophic nail dystrophy, painful and highly debilitating plantar keratoderma, oral leukokeratosis, and a variety of epidermal cysts.

Related Diseases for Pachyonychia Congenita 3

Diseases in the Pachyonychia Congenita, Autosomal Recessive family:

Pachyonychia Congenita 1 Pachyonychia Congenita 2
Pachyonychia Congenita 3 Pachyonychia Congenita 4

Diseases related to Pachyonychia Congenita 3 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 88, show less)
# Related Disease Score Top Affiliating Genes
1 prostate cancer 11.0
2 suppression of tumorigenicity 12 10.4
3 insulin-like growth factor i 10.3
4 bone resorption disease 10.3
5 retinoblastoma 10.3
6 pertussis 10.3
7 insulinoma 10.3
8 familial retinoblastoma 10.3
9 severe combined immunodeficiency 10.3
10 48,xyyy 10.2
11 osteogenic sarcoma 10.2
12 fibrosarcoma 10.2
13 rapidly involuting congenital hemangioma 10.2
14 skin disease 10.2
15 pituitary tumors 10.2
16 hypertriglyceridemia, familial 10.1
17 multicentric carpotarsal osteolysis syndrome 10.1
18 glioblastoma multiforme 10.1
19 breast cancer 10.1
20 prostatic hyperplasia, benign 10.1
21 prostate cancer, hereditary, 3 10.1
22 familial adenomatous polyposis 10.1
23 small cell carcinoma 10.1
24 prostatic hypertrophy 10.1
25 prostatitis 10.1
26 cholera 10.1
27 prostatic adenoma 10.1
28 adenocarcinoma 10.1
29 vaccinia 10.1
30 pituitary adenoma 10.1
31 adenoma 10.1
32 hypoxia 10.1
33 pancreatic cancer 10.0
34 ataxia and polyneuropathy, adult-onset 10.0
35 leukemia, acute lymphoblastic 10.0
36 colorectal adenocarcinoma 10.0
37 bone disease 10.0
38 microcephaly 10.0
39 neutropenia 10.0
40 dysentery 10.0
41 leukemia 10.0
42 urethritis 10.0
43 cystitis 10.0
44 hyperinsulinism 10.0
45 iron metabolism disease 10.0
46 astrocytoma 10.0
47 breast adenocarcinoma 10.0
48 hyperglycemia 10.0
49 t-cell acute lymphoblastic leukemia 10.0
50 neuroblastoma 10.0
51 myeloid leukemia 10.0
52 skin melanoma 10.0
53 lymphosarcoma 10.0
54 precursor t-cell acute lymphoblastic leukemia 10.0
55 neurofibromatosis, type ii 9.9
56 alopecia, androgenetic, 1 9.9
57 colorectal cancer 9.9
58 hypercholesterolemia, familial, 1 9.9
59 endosteal hyperostosis, autosomal dominant 9.9
60 medulloblastoma 9.9
61 antigen defined by monoclonal antibody aj9 9.9
62 pheochromocytoma 9.9
63 greig cephalopolysyndactyly syndrome 9.9
64 triiodothyronine receptor auxiliary protein 9.9
65 ataxia-telangiectasia 9.9
66 hypogonadotropic hypogonadism 1 with or without anosmia 9.9
67 leukemia, acute myeloid 9.9
68 nasopharyngeal carcinoma 9.9
69 acute promyelocytic leukemia 9.9
70 gastric cancer 9.9
71 pulmonary hypertension, primary, 2 9.9
72 mulchandani-bhoj-conlin syndrome 9.9
73 helix syndrome 9.9
74 androgenic alopecia 9.9
75 adrenal gland pheochromocytoma 9.9
76 autosomal recessive cerebellar ataxia 9.9
77 lymph node carcinoma 9.9
78 telangiectasis 9.9
79 neuroendocrine carcinoma 9.9
80 skin carcinoma 9.9
81 kallmann syndrome 9.9
82 cervical adenocarcinoma 9.9
83 b-cell lymphoma 9.9
84 alopecia 9.9
85 cytomegalovirus infection 9.9
86 cerebrofacial arteriovenous metameric syndrome 9.9
87 pre-descemet corneal dystrophy 9.9
88 argyria 9.9

Graphical network of the top 20 diseases related to Pachyonychia Congenita 3:



Diseases related to Pachyonychia Congenita 3

Symptoms & Phenotypes for Pachyonychia Congenita 3

Human phenotypes related to Pachyonychia Congenita 3:

31 (showing 11, show less)
# Description HPO Frequency HPO Source Accession
1 hyperhidrosis 31 HP:0000975
2 palmoplantar keratoderma 31 HP:0000982
3 gingivitis 31 HP:0000230
4 furrowed tongue 31 HP:0000221
5 oral leukoplakia 31 HP:0002745
6 nail dystrophy 31 HP:0008404
7 plantar hyperkeratosis 31 HP:0007556
8 onychogryposis of toenails 31 HP:0008401
9 epidermoid cyst 31 HP:0200040
10 palmar hyperkeratosis 31 HP:0010765
11 chapped lip 31 HP:0040181

Symptoms via clinical synopsis from OMIM:

56
Skin Nails Hair Skin:
palmoplantar keratoderma
follicular hyperkeratosis
pilosebaceous cysts
steatocystoma

Skin Nails Hair Nails:
pachyonychia

Head And Neck Eyes:
conjunctival hyperkeratosis (rare)

Skeletal Feet:
plantar keratoderma
plantar fissures
plantar pain

Voice:
hoarse voice

Head And Neck Mouth:
fissured tongue
oral leukokeratosis
dry, chapped lips
tongue leukokeratosis

Skeletal Hands:
palmar keratoderma

Clinical features from OMIM:

615726

Drugs & Therapeutics for Pachyonychia Congenita 3

Drugs for Pachyonychia Congenita 3 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 23, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Remifentanil Approved Phase 4 132875-61-7 60815
2 Narcotics Phase 4
3 Analgesics Phase 4
4 Anesthetics Phase 4
5 Analgesics, Opioid Phase 4
6
Epirubicin Approved Phase 3 56420-45-2 41867
7
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
8
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
9
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
10 Tubulin Modulators Phase 3
11 Antimitotic Agents Phase 3
12 Immunologic Factors Phase 3
13 Albumin-Bound Paclitaxel Phase 3
14 Alkylating Agents Phase 3
15 Immunosuppressive Agents Phase 3
16 Anti-Bacterial Agents Phase 3
17 Antibiotics, Antitubercular Phase 3
18 Antirheumatic Agents Phase 3
19
Gefitinib Approved, Investigational Phase 2 184475-35-2 123631
20
Docetaxel Approved, Investigational Phase 2 114977-28-5 148124
21 Protein Kinase Inhibitors Phase 2
22
Parathyroid hormone Approved, Investigational 9002-64-6
23 Liver Extracts

Interventional clinical trials:

(showing 6, show less)
# Name Status NCT ID Phase Drugs
1 Effect of Two Plasma Concentrations of Remifentanil Through Target Controlled Anesthesia on Frequency and Intensity of Coughing During Extubation: Randomized Controlled Clinical Trial Completed NCT02711904 Phase 4 Extubation U;Extubation T
2 Randomized Phase Ⅲ Trial Comparing Dose-dense Epirubicin and Cyclophosphamide Followed by Paclitaxel With Paclitaxel Plus Carboplatin as Adjuvant Therapy for Triple-negative Breast Cancer. Unknown status NCT01378533 Phase 3 epirubicin, cyclophosphamide, paclitaxel, carboplatin, G-CSF
3 Phase II Trial of Neoadjuvant Docetaxel and ZD 1839 (Iressa) Followed by Radical Prostatectomy in Patients With High Risk, Locally Advanced Prostate Cancer Completed NCT00242918 Phase 2 docetaxel;ZD1839
4 Effect and Mechanism of Acupuncture on Patients With Functional Dyspepsia: a Protocol for a Randomized, Assessor-blind, Sham-controlled Trial Unknown status NCT02358486
5 Improving Pain Management in Cancer Care Completed NCT00036829
6 Intervention Based on the Use of Patient Feedback Collected for Improving Patient Safety in Spanish Primary Care (PC) Centres Active, not recruiting NCT03837912

Search NIH Clinical Center for Pachyonychia Congenita 3

Genetic Tests for Pachyonychia Congenita 3

Genetic tests related to Pachyonychia Congenita 3:

# Genetic test Affiliating Genes
1 Pachyonychia Congenita 3 29 KRT6A

Anatomical Context for Pachyonychia Congenita 3

MalaCards organs/tissues related to Pachyonychia Congenita 3:

40
Prostate, Bone, Breast, Endothelial, Lung, Colon, Tongue

Publications for Pachyonychia Congenita 3

Articles related to Pachyonychia Congenita 3:

(showing 7317, show less)
# Title Authors PMID Year
1
The molecular genetic analysis of the expanding pachyonychia congenita case collection. 56 6
24611874 2014
2
Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma. 6 56
22668561 2012
3
The genetic basis of pachyonychia congenita. 6 56
16250206 2005
4
Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita. 6 56
11886499 2001
5
Mutation of a type II keratin gene (K6a) in pachyonychia congenita. 56 6
7545493 1995
6
Revisiting pachyonychia congenita: a case-cohort study of 815 patients. 56
31823354 2020
7
Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children. 56
31777952 2020
8
Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation. 56
30307612 2019
9
Pachyonychia congenita in pediatric patients: natural history, features, and impact. 56
24132595 2014
10
A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. 56
22264670 2012
11
Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16. 56
22098151 2012
12
The phenotypic and molecular genetic features of pachyonychia congenita. 56
21430705 2011
13
Pachyonychia Congenita 6
20301457 2006
14
A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. 56
9618173 1998
15
A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. 6
7493030 1995
16
Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity. 61
32208781 2020
17
Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment. 61
31967481 2020
18
3D porous chitosan-chondroitin sulfate scaffolds promote epithelial to mesenchymal transition in prostate cancer cells. 61
32480094 2020
19
Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo. 61
32319597 2020
20
Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61. 61
32044796 2020
21
Epigenetic regulation of the ITGB4 gene in prostate cancer. 61
32376286 2020
22
Nickel and zinc complexes of testosterone N4-substituted thiosemicarbazone: Selective cytotoxicity towards human colorectal carcinoma cell line HCT 116 and their cell death mechanisms. 61
32438269 2020
23
Anticancer and Antibacterial Activities of Silver Nanoparticles (AgNPs) Synthesized from Cucumis melo L. 61
31968432 2020
24
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine. 61
32447069 2020
25
Synthesis and anticancer activity of open-resorcinarene conjugates. 61
32527536 2020
26
The influence of hypoxia on the prostate cancer proteome. 61
31940282 2020
27
Can ultrasound irradiation be a therapeutic option for prostate cancer? 61
32557725 2020
28
NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p. 61
32249364 2020
29
Selenium-binding protein 1 alters energy metabolism in prostate cancer cells. 61
32511787 2020
30
SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair. 61
32512734 2020
31
Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer. 61
32498336 2020
32
Biological Synthesis of CdTe Quantum Dots and Their Anti-Proliferative Assessment Against Prostate Cancer Cell Line. 61
31748032 2020
33
Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer. 61
32556998 2020
34
A Multimodal Theranostic Nanoformulation that Dramatically Enhances Docetaxel Efficacy Against Castration Resistant Prostate Cancer. 61
32534879 2020
35
Lipid droplets in prostate cancer cells and effect of irradiation studied by Raman microspectroscopy. 61
32504818 2020
36
Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK/ERK signaling pathway. 61
32561286 2020
37
Synthesis of bioactive quinazolin-4(3H)-one derivatives via microwave activation tailored by phase-transfer catalysis. 61
31955144 2020
38
Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application. 61
32169777 2020
39
Radiosynthesis and preclinical evaluation of [18F]FEM as a potential novel PET probe for tumor imaging. 61
32354567 2020
40
A promising therapeutic combination for metastatic prostate cancer: Chloroquine as autophagy inhibitor and palladium(II) barbiturate complex. 61
32497551 2020
41
An Efficient Near-Infrared Emissive Artificial Supramolecular Light-Harvesting System for Imaging in the Golgi Apparatus. 61
32196893 2020
42
Isoenzyme-Selective Inhibitors of Human Neuraminidases Reveal Distinct Effects on Cell Migration. 61
32310634 2020
43
Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents. 61
32283346 2020
44
Cytotoxic xanthone derivatives from the twigs of Garcinia oligantha. 61
32203742 2020
45
Determination of anticancer properties and inhibitory effects of some metabolic enzymes including acetylcholinesterase, butyrylcholinesterase, alpha-glycosidase of some compounds with molecular docking study. 61
32406329 2020
46
Supercritical fluid assembly of albendazole liposomes targeting gastrin-releasing peptide receptor overexpressing tumors. 61
32484025 2020
47
Evaluation of a New 99mTc-labeled GnRH Analogue as a Possible Imaging Agent for Prostate Cancer Detection. 61
32560611 2020
48
Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of 99mTc-Tricarbonyl-Based Radiopharmaceuticals. 61
32527027 2020
49
Synthesis, distribution analysis and mechanism studies of N-acyl glucosamine-bearing oleanolic saponins. 61
32305695 2020
50
Akt/survivin pathway inhibition enhances the apoptotic cell death-induced by alpha-santalol in human prostate cancer cells. 61
32173422 2020
51
Highly Oxygenated Constituents from a Marine Alga-Derived Fungus Aspergillus giganteus NTU967. 61
32517237 2020
52
Azidothymidine "Clicked" into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual-Hybrid Inhibitors. 61
32463228 2020
53
The Effect of Optically Induced Dielectrophoresis (ODEP)-Based Cell Manipulation in a Microfluidic System on the Properties of Biological Cells. 61
32560153 2020
54
Exploration of certain 1,3-oxazole- and 1,3-thiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents. 61
32534346 2020
55
Mechanism of selective anticancer activity of isothiocyanates relies on differences in DNA damage repair between cancer and healthy cells. 61
31123866 2020
56
The effects of spacer on radiochemical and biological properties of new radiolabeled bombesin(7-14) derivative. 61
32497000 2020
57
Chrysosplenol d, a Flavonol from Artemisia annua, Induces ERK1/2-Mediated Apoptosis in Triple Negative Human Breast Cancer Cells. 61
32521698 2020
58
Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity. 61
31932492 2020
59
Antiproliferative and apoptogenic effects of Cassia fistula L. n-hexane fraction against human cervical cancer (HeLa) cells. 61
32504442 2020
60
Myricitrin from Combretum lanceolatum Exhibits Inhibitory Effect on DNA-Topoisomerase Type IIα and Protective Effect Against In Vivo Doxorubicin-Induced Mutagenicity. 61
32543997 2020
61
4,4'-Diisothiocyanatostilbene-2,2'-disulfonate modulates voltage-gated K+ current and influences cell cycle arrest in androgen sensitive and insensitive human prostate cancer cell lines. 61
32193973 2020
62
Isolobetyol, a new polyacetylene derivative from Platycodon grandiflorum root. 61
32573262 2020
63
A new phenolic compound from Phedimus middendorffianus with antiproliferative activity. 61
30470138 2020
64
SOX7 is involved in polyphyllin D-induced G0/G1 cell cycle arrest through down-regulation of cyclin D1. 61
31955140 2020
65
Characterization of ankaflavin from Penicillium aculeatum and its cytotoxic properties. 61
30587035 2020
66
Synthesis, biological evaluation and model membrane studies on metal complexes containing aromatic N,O-chelate ligands. 61
32548326 2020
67
Effects of benzoic acid, Bacillus coagulans and oregano oil combined supplementation on growth performance, immune status and intestinal barrier integrity of weaned piglets. 61
32542195 2020
68
Preclinical anticancer studies on the ethyl acetate leaf extracts of Datura stramonium and Datura inoxia. 61
32552791 2020
69
Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes. 61
32278205 2020
70
Combined targeting of EGFR and HER2 against prostate cancer stem cells. 61
32089070 2020
71
Docetaxel-resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1. 61
32134535 2020
72
Synthesis of Tamoxifen-Artemisinin and Estrogen-Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer. 61
32374071 2020
73
ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis. 61
32415173 2020
74
Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells. 61
32043710 2020
75
The Role of Lysosome-Associated Membrane Protein 2 in Prostate Cancer Chemopreventive Mechanisms of Sulforaphane. 61
32434809 2020
76
MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2. 61
32432734 2020
77
Active vitamin D induces gene-specific hypomethylation in prostate cancer cells developing vitamin D resistance. 61
32159363 2020
78
Synthesis and biological evaluation of 6-phenylpurine linked hydroxamates as novel histone deacetylase inhibitors. 61
32171983 2020
79
Triterpene glycosides from Silene odontopetala. 61
32447090 2020
80
G3BP1-linked mRNA partitioning supports selective protein synthesis in response to oxidative stress. 61
32406909 2020
81
Determining the Relative Gene Expression Level of Hypoxia Related Genes in Different Cancer Cell Lines. 61
32436837 2020
82
Arginine deaminase from Pseudomonas aeruginosa PS2: purification, biochemical characterization and in-vitro evaluation of anticancer activity. 61
32373418 2020
83
Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile. 61
32486054 2020
84
Lactoquinomycin C and D, two new medermycin derivatives from the marine-derived Streptomyces sp. SS17A. 61
30806517 2020
85
Regioselective synthesis and evaluation of 2-amino 3-cyano chromene-chrysin hybrids as potential anticancer agents. 61
32160978 2020
86
Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect. 61
32422489 2020
87
Design, Synthesis and Bioevaluation of Two Series of 3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones and N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines. 61
32356584 2020
88
Radiodynamic therapy using 15-MV radiation combined with 5-aminolevulinic acid and carbamide peroxide for prostate cancer <i>in vivo</i>. 61
32464613 2020
89
Comparison between high definition FT-IR, Raman and AFM-IR for subcellular chemical imaging of cholesteryl esters in prostate cancer cells. 61
31999078 2020
90
Characterization of a novel automated microfiltration device for the efficient isolation and analysis of circulating tumor cells from clinical blood samples. 61
32372001 2020
91
Synthesis and biological evaluation of a new series of 1-aryl-3-[4-(pyridin-2-ylmethoxy)phenyl]urea derivatives as new anticancer agents. 61
32427204 2020
92
Exploring the Sequence Diversity of Cyclotides from Vietnamese Viola Species. 61
32437150 2020
93
Upregulation of pERK and c-JUN by γ-tocotrienol and not α-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells. 61
32414345 2020
94
Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives using 5,6,8,9-tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione. 61
32445457 2020
95
Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors. 61
32199690 2020
96
4-Hydroxy-3-methylbenzofuran-2-carbohydrazones as novel LSD1 inhibitors. 61
32201021 2020
97
New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies. 61
32197148 2020
98
Highly Promising Antitumor Agent of a Novel Platinum(II) Complex Bearing a Tetradentate Chelating Ligand. 61
32435409 2020
99
Synthesis and Potential Anticancer Activity of Some Novel Selenocyanates and Diselenides. 61
32198823 2020
100
The near-infrared fluorescent dye IR-780 was coupled with cabazitaxel for castration-resistant prostate cancer imaging and therapy. 61
32361788 2020
101
Radiosynthesis, in vitro and preliminary biological evaluation of [18 F]FABABA, a novel ASCT-2 inhibitor based PET tracer. 61
32472945 2020
102
m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1. 61
32329830 2020
103
Capsaicin suppressed activity of prostate cancer stem cells by inhibition of Wnt/β-catenin pathway. 61
31782192 2020
104
Assessment of various formulation approaches for the application of beta-lapachone in prostate cancer therapy. 61
32087264 2020
105
Fish Lipid against Prostate Cancer (PC-3) through Apoptosis and Cell Cycle Arrest. 61
32242459 2020
106
Fatty-Acid Uptake in Prostate Cancer Cells Using Dynamic Microfluidic Raman Technology. 61
32260207 2020
107
Identification of retinoid acid induced 16 as a novel androgen receptor target in prostate cancer cells. 61
32014455 2020
108
Arctigenin induces necroptosis through mitochondrial dysfunction with CCN1 upregulation in prostate cancer cells under lactic acidosis. 61
32065351 2020
109
TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway. 61
31981447 2020
110
Best Practice Framework of Fracture Liaison Services in Spain and their coordination with Primary Care. 61
32335759 2020
111
Microtube Array Membrane (MTAM)-Based Encapsulated Cell Therapy for Cancer Treatment. 61
32357523 2020
112
Biological activities of marine invertebrates extracts from the northeast brazilian coast. 61
31389485 2020
113
Synthesis and anti-tumour, immunomodulating activity of diosgenin and tigogenin conjugates. 61
32017993 2020
114
Synthesis, biological evaluation and molecular modeling study of [1,2,4]-Triazolo[4,3-c]quinazolines: New class of EGFR-TK inhibitors. 61
32085964 2020
115
Discovery of novel tertiary amide derivatives as NEDDylation pathway activators to inhibit the tumor progression in vitro and in vivo. 61
32135407 2020
116
Detecting TRA-1-60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent. 61
32069422 2020
117
Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells. 61
32048561 2020
118
Synthesis, 18F-radiolabeling and apoptosis inducing studies of novel 4, 7-disubstituted coumarins. 61
32106038 2020
119
Antioxidant and anti-tumour activity of triterpenoid compounds isolated from Morchella mycelium. 61
32285166 2020
120
Mitochondrial-Targeted and Near-Infrared Fluorescence Probe for Bioimaging and Evaluating Monoamine Oxidase A Activity in Hepatic Fibrosis. 61
32223138 2020
121
Cytotoxic triterpenoid glycosides from leaves of Cyclocarya paliurus. 61
32316785 2020
122
Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models. 61
32054790 2020
123
Experimental Biology 2020 Meeting Abstracts. 61
32297350 2020
124
Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer. 61
31702068 2020
125
Anticancer evaluation of a novel dithiocarbamate hybrid as the tubulin polymerization inhibitor. 61
31183632 2020
126
Prostate and breast cancer cells death induced by xanthohumol investigated with Fourier transform infrared spectroscopy. 61
32014658 2020
127
Hyaluronan-Metal Gold Nanoparticle Hybrids for Targeted Tumor Cell Therapy. 61
32349323 2020
128
Bifunctional Au-templated RNA nanoparticles enable direct cell uptake detection and GRP75 knockdown in prostate cancer. 61
32096520 2020
129
γ-Klotho is correlated with resistance to docetaxel in castration-resistant prostate cancer. 61
32194730 2020
130
Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer. 61
31241767 2020
131
New Acetohydrazides Incorporating 2-Oxoindoline and 4-Oxoquinazoline: Synthesis and Evaluation of Cytotoxicity and Caspase Activation Activity. 61
31943757 2020
132
In Vitro Anti-Prostate Cancer Activity of Two Ebselen Analogues. 61
32192052 2020
133
Ascleposide, a natural cardenolide, induces anticancer signaling in human castration-resistant prostatic cancer through Na+ /K+ -ATPase internalization and tubulin acetylation. 61
31905252 2020
134
Synthesis and Design of Norfloxacin drug delivery system based on PLA/TiO2 nanocomposites: Antibacterial and antitumor activities. 61
31923987 2020
135
VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer. 61
32218194 2020
136
A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells. 61
31476841 2020
137
Study of oxyresveratrol complexes with insoluble cyclodextrin based nanosponges: Developing a novel way to obtain their complexation constants and application in an anticancer study. 61
31888848 2020
138
Anticancer and antibacterial potential of Rhus punjabensis and CuO nanoparticles. 61
30320505 2020
139
Synthesis of flavonoids nitrogen mustard derivatives and study on their antitumor activity in vitro. 61
32028061 2020
140
Pomegranate Juice and Peel Extracts are Able to Inhibit Proliferation, Migration and Colony Formation of Prostate Cancer Cell Lines and Modulate the Akt/mTOR/S6K Signaling Pathway. 61
31838616 2020
141
Evodiamine Mitigates Cellular Growth and Promotes Apoptosis by Targeting the c-Met Pathway in Prostate Cancer Cells. 61
32183146 2020
142
Multifaceted Function of MicroRNA-299-3p Fosters an Antitumor Environment Through Modulation of Androgen Receptor and VEGFA Signaling Pathways in Prostate Cancer. 61
32198489 2020
143
Three-Component Reaction of Diamines with Triethyl Orthoformate and Diethyl Phosphite and Anti-Proliferative and Antiosteoporotic Activities of the Products. 61
32245019 2020
144
Automated radiosynthesis and preclinical evaluation of Al[18F]F-NOTA-P-GnRH for PET imaging of GnRH receptor-positive tumors. 61
32088580 2020
145
SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation. 61
32209980 2020
146
A remarkable in vitro cytotoxic, cell cycle arresting and proapoptotic characteristics of low-dose mixed micellar simvastatin combined with alendronate sodium. 61
32221848 2020
147
Development of 18F-Fluoroglycosylated PSMA-Ligands with Improved Renal Clearance Behavior. 61
32011889 2020
148
Development of Improved Tumor-Residualizing, GRPR-Targeted Agents: Preclinical Comparison of an Endolysosomal Trapping Approach in Agonistic and Antagonistic Constructs. 61
31601697 2020
149
New flavonoids, emarginin A-C from Vaccinium emarginatum Hayata. 61
31790770 2020
150
VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents. 61
31992477 2020
151
A new xanthyletin-type coumarin from the roots of Peucedanum praeruptorum. 61
30621449 2020
152
Suppression of α-methylacyl-coenzyme A racemase by miR200c inhibits prostate adenocarcinoma cell proliferation and migration. 61
32104236 2020
153
Effects of gametogenetin-binding protein 2 on proliferation, invasion and migration of prostate cancer PC-3 cells. 61
31797427 2020
154
A Camera Sensors-Based System to Study Drug Effects On In Vitro Motility: The Case of PC-3 Prostate Cancer Cells. 61
32164292 2020
155
Role of Reactive Oxygen Species in the Cytotoxicity of Arsenic Trioxide and Pamidronate for Human Prostate Cancer Cells. 61
32337366 2020
156
Ginseng Gintonin Contains Ligands for GPR40 and GPR55. 61
32121640 2020
157
Prostate Cancer Phenotype Influences Bone Mineralization at Metastasis: A Study Using an In Vitro Prostate Cancer Metastasis Testbed. 61
32083238 2020
158
Post-SELEX Optimization and Characterization of a Prostate Cancer Cell-Specific Aptamer for Diagnosis. 61
32118168 2020
159
Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer. 61
31816356 2020
160
Stevia eupatoria and Stevia pilosa Extracts Inhibit the Proliferation and Migration of Prostate Cancer Cells. 61
32102219 2020
161
Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in Prostate Cancer Cells. 61
32070055 2020
162
MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression. 61
31876385 2020
163
GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells. 61
31760076 2020
164
Gold nanoparticle clusters for the investigation of therapeutic efficiency against prostate cancer under near-infrared irradiation. 61
32064551 2020
165
Antioxidant, Antiproliferative and Apoptosis-Inducing Efficacy of Fractions from Cassia fistula L. Leaves. 61
32093300 2020
166
Papain mediated synthesized gold nanoparticles encore the potency of bioconjugated Flutamide. 61
32106799 2020
167
Mixed ligand complexes of Co(II), Ni(II) and Cu(II) with quercetin and diimine ligands: synthesis, characterization, anti-cancer and anti-oxidant activity. 61
31832781 2020
168
Encapsulation of Variabilin in Stearic Acid Solid Lipid Nanoparticles Enhances Its Anticancer Activity in Vitro. 61
32074951 2020
169
Apoptosis induction in lung and prostate cancer cells through silver nanoparticles synthesized from Pinus roxburghii bioactive fraction. 61
31641851 2020
170
Apigenin as an anticancer agent. 61
32059077 2020
171
Development of selective mono or dual PROTAC degrader probe of CDK isoforms. 61
31846828 2020
172
Synthesis and anti-cancer activity studies of dammarane-type triterpenoid derivatives. 61
31862444 2020
173
Probing two PESIN-indocyanine-dye-conjugates: significance of the used fluorophore. 61
31967633 2020
174
Comparison of biological properties of [177 Lu]Lu-ProBOMB1 and [177 Lu]Lu-NeoBOMB1 for GRPR targeting. 61
31715025 2020
175
Triterpenoids from the barks of Juglans hopeiensis. 61
31778881 2020
176
Expansion of chemical space based on a pyrrolo[1,2-a]pyrazine core: Synthesis and its anticancer activity in prostate cancer and breast cancer cells. 61
31901746 2020
177
Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment. 61
31826492 2020
178
Design, Synthesis, and Biological Evaluation of Two Series of Novel A-Ring Fused Steroidal Pyrazines as Potential Anticancer Agents. 61
32121303 2020
179
Meeting organometallic chemistry with drug discovery: CH activation enabled discovery of a new ring system of 12H-Indazolo[2,1-a]cinnolin-12-ones with anti-proliferation activity. 61
31889668 2020
180
Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer. 61
31025163 2020
181
Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3). 61
31883489 2020
182
Calcitriol inhibits lipopolysaccharide-induced proliferation, migration and invasion of prostate cancer cells through suppressing STAT3 signal activation. 61
32120344 2020
183
Rosa canina Extract has Antiproliferative and Proapoptotic Effects on Human Lung and Prostate Cancer Cells. 61
31184219 2020
184
Glycyrrhiza glabra-Enhanced Extract and Adriamycin Antiproliferative Effect on PC-3 Prostate Cancer Cells. 61
31274029 2020
185
Inhibition of prostate cancer cell line (PC-3) by anhydrodihydroartemisinin (ADHA) through caspase-dependent pathway. 61
32483407 2020
186
miR-223-5p targeting ERG inhibits prostate cancer cell proliferation and migration. 61
32489464 2020
187
Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways. 61
32174789 2020
188
Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells. 61
31894360 2020
189
Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. 61
31902674 2020
190
γ-Tocotrienol and α-Tocopherol Ether Acetate Enhance Docetaxel Activity in Drug-Resistant Prostate Cancer Cells. 61
31963634 2020
191
Brevifoliol ester induces apoptosis in prostate cancer cells by activation of caspase pathway. 61
31585016 2020
192
Prostate Cancer Cellular Uptake of Ternary Titanate Nanotubes/CuFe2O4/Zn-Fe Mixed Metal Oxides Nanocomposite. 61
32099355 2020
193
Germacrone Induces Apoptosis as Well as Protective Autophagy in Human Prostate Cancer Cells. 61
32547235 2020
194
Determining the prevalence and severity of cancer cachexia in advanced non-small cell lung cancer and its relationship with chemotherapy outcomes. 61
31916005 2020
195
Antioxidation and Antiapoptosis Characteristics of Heme Oxygenase-1 Enhance Tumorigenesis of Human Prostate Carcinoma Cells. 61
31810001 2020
196
New steroidal oxazolines, benzoxazoles and benzimidazoles related to abiraterone and galeterone. 61
31678134 2020
197
Analysis of the Potential for N4-Hydroxycytidine To Inhibit Mitochondrial Replication and Function. 61
31767721 2020
198
Synthesis, Anticancer, and Antibacterial Activity of Betulinic and Betulonic Acid C-28-Triphenylphosphonium Conjugates with Variable Alkyl Linker Length. 61
31660842 2020
199
Quercetin Inhibits Epithelial-to-Mesenchymal Transition (EMT) Process and Promotes Apoptosis in Prostate Cancer via Downregulating lncRNA MALAT1. 61
32210615 2020
200
Citral Induced Apoptosis through Modulation of Key Genes Involved in Fatty Acid Biosynthesis in Human Prostate Cancer Cells: In Silico and In Vitro Study. 61
32258129 2020
201
Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis. 61
31654872 2020
202
Synthesis and pharmacological evaluation of naftopidil-based arylpiperazine derivatives containing the bromophenol moiety. 61
32048266 2020
203
Design, synthesis and biological evaluation of novel indole-based oxalamide and aminoacetamide derivatives as tubulin polymerization inhibitors. 61
31753698 2020
204
Design and Synthesis of New Substituted Pyrazolopyridines with Potent Antiproliferative Activity. 61
30799794 2020
205
Apoptosis: A target for anticancer therapy with novel cyanopyridines. 61
31837830 2020
206
The Yemeni Brown Algae Dictyota dichotoma Exhibit High In Vitro Anticancer Activity Independent of Its Antioxidant Capability. 61
32149090 2020
207
The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth. 61
31222811 2020
208
Components from the Human c-myb Transcriptional Regulation System Reactivate Epigenetically Repressed Transgenes. 61
31947658 2020
209
College Education on Dietary Supplements May Promote Responsible Use In Young Adults. 61
30252551 2020
210
Synthesis and evaluation of the antitumor activity of Calix[4]arene l-proline derivatives. 61
31451296 2020
211
Eupalinolide J induces apoptosis, cell cycle arrest, mitochondrial membrane potential disruption and DNA damage in human prostate cancer cells. 61
31932554 2020
212
Design, synthesis and biological evaluation of new Axl kinase inhibitors containing 1,3,4-oxadiazole acetamide moiety as novel linker. 61
31757525 2020
213
2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents. 61
31761381 2020
214
Straightforward synthesis, characterization, and cytotoxicity evaluation of hybrids of natural alkaloid evodiamine/rutaecarpine and thieno[2,3-d]pyrimidinones. 61
30588834 2020
215
Quantitative SWATH-Based Proteomic Profiling for Identification of Mechanism-Driven Diagnostic Biomarkers Conferring in the Progression of Metastatic Prostate Cancer. 61
32322560 2020
216
Novel GH-20 β-N-acetylglucosaminidase inhibitors: Virtual screening, molecular docking, binding affinity, and anti-tumor activity. 61
31593714 2020
217
"A Sweet Combination": Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII. 61
31794211 2020
218
Active mixture of serum-circulating small molecules selectively inhibits proliferation and triggers apoptosis in cancer cells via induction of ER stress. 61
31669205 2020
219
Design, synthesis, cytotoxicity screening and molecular docking of new 3-cyanopyridines as survivin inhibitors and apoptosis inducers. 61
31679838 2020
220
Peimine inhibits the growth and motility of prostate cancer cells and induces apoptosis by disruption of intracellular calcium homeostasis through Ca2+ /CaMKII/JNK pathway. 61
31081133 2020
221
Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors. 61
31922057 2020
222
Apoptotic effects of thymol, a novel monoterpene phenol, on different types of cancer. 61
32115964 2020
223
Preliminary Evaluation of Astatine-211-Labeled Bombesin Derivatives for Targeted Alpha Therapy. 61
32475858 2020
224
Geranylated 4-phenylcoumarins extracted from Mesua elegans induced caspase-independent cell death in prostate cancer cell lines through calpain-2 and cathepsin B. 61
31969640 2020
225
Aptamer-Conjugated Multifunctional Polymeric Nanoparticles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems for Treatment of Castration-Resistant Prostate Cancer. 61
32420382 2020
226
Estrogen Receptors Promote Migration, Invasion and Colony Formation of the Androgen-Independent Prostate Cancer Cells PC-3 Through β-Catenin Pathway. 61
32328032 2020
227
Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells. 61
31936664 2020
228
A novel pregnene analogs: synthesis, cytotoxicity on prostate cancer of PC-3 and LNCPa-AI cells and in silico molecular docking study. 61
32006297 2020
229
Quercetin Enhanced Paclitaxel Therapeutic Effects Towards PC-3 Prostate Cancer Through ER Stress Induction and ROS Production. 61
32021294 2020
230
In silico studies of piperazine derivatives as potent anti-proliferative agents against PC-3 prostate cancer cell lines. 61
32021936 2020
231
Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity. 61
32042329 2020
232
Engineering of Trichoderma reesei for enhanced degradation of lignocellulosic biomass by truncation of the cellulase activator ACE3. 61
32266008 2020
233
Targeting eIF5A2 inhibits prostate carcinogenesis, migration, invasion and metastasis in vitro and in vivo. 61
32522053 2020
234
CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7. 61
31437604 2020
235
Comparison of Chemical Composition and Bioactivities of Essential Oils from Fresh and Dry Rhizomes of Zingiber zerumbet (L.) Smith. 61
32104711 2020
236
Synthesis and Photodynamic Activity of Vitamin-Chlorin Conjugates at Nanomolar Concentrations against Prostate Cancer Cells. 61
31891050 2019
237
Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane. 61
31555797 2019
238
A Novel Small Molecule Inhibits Tumor Growth and Synergizes Effects of Enzalutamide on Prostate Cancer. 61
31582422 2019
239
MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF. 61
30669858 2019
240
(E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity. 61
30734614 2019
241
Carbohydrate Modifications of Neoandrographolide for Improved Reactive Oxygen Species-Mediated Apoptosis through Mitochondrial Pathway in Colon Cancer. 61
31858026 2019
242
Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent. 61
31831761 2019
243
Global and region-specific post-transcriptional and post-translational modifications of bisphenol A in human prostate cancer cells. 61
31610501 2019
244
Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process. 61
31509289 2019
245
Kochia scoparia seed extract suppresses VEGF-induced angiogenesis via modulating VEGF receptor 2 and PI3K/AKT/mTOR pathways. 61
31608754 2019
246
Isolation, characterization, and bioactivities of compounds from Fuscoporia torulosa mushroom. 61
31599026 2019
247
Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer. 61
31578782 2019
248
Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles. 61
32255916 2019
249
Synthesis and cytotoxic activities of novel copper and silver complexes of 1,3-diaryltriazene-substituted sulfonamides. 61
30362387 2019
250
Metabolic Profiling of the Soft Coral Erythropodium caribaeorum (Alcyonacea: Anthothelidae) from the Colombian Caribbean Reveals Different Chemotypes. 61
31861453 2019
251
Cytotoxic Stilbenes and Canthinone Alkaloids from Brucea antidysenterica (Simaroubaceae). 61
31816856 2019
252
Enhancement of curcumin antitumor efficacy and further photothermal ablation of tumor growth by single-walled carbon nanotubes delivery system in vivo. 61
31578087 2019
253
Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists. 61
31469015 2019
254
Ligands dissociation induced gold nanoparticles aggregation for colorimetric Al3+ detection. 61
31585569 2019
255
Sericin grafted multifunctional curcumin loaded fluorinated graphene oxide nanomedicines with charge switching properties for effective cancer cell targeting. 61
31678390 2019
256
In vitro antitumor activity, ADME-Tox and 3D-QSAR of synthesized and selected natural styryl lactones. 61
31480006 2019
257
circSMAD2 governs migration and epithelial-mesenchymal transition by inhibiting microRNA-9. 61
31886568 2019
258
γ-(S)-Guanidinylmethyl-Modified Triplex-Forming Peptide Nucleic Acids Increase Hoogsteen-Face Affinity for a MicroRNA and Enhance Cellular Uptake. 61
31206960 2019
259
Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer. 61
30815792 2019
260
The Effect of Chirality on the Application of 5-[18F]Fluoro-Aminosuberic Acid ([18F]FASu) for Oxidative Stress Imaging. 61
31792837 2019
261
Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairing effect in human prostate cancer cell line PC-3. 61
31571107 2019
262
Novel tertiary sulfonamide derivatives containing benzimidazole moiety as potent anti-gastric cancer agents: Design, synthesis and SAR studies. 61
31577977 2019
263
Anticancer Activity of Earthworm Powder (Lumbricus terrestris) Against MCF-7 and PC-3 Cancer Cell Lines. 61
31321664 2019
264
Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist 177 Lu-DOTAGA-PEG2 -RM26. 61
31077356 2019
265
Stylosin and some of its synthetic derivatives induce apoptosis in prostate cancer cells as 15-lipoxygenase enzyme inhibitors. 61
31297564 2019
266
Cytotoxic Activity of Sesquiterpenoids Isolated from Endemic Ferula tenuissima Hub.-Mor & Peşmen. 61
32454752 2019
267
Nonradioactive Cell Assay for the Evaluation of Modular Prostate-Specific Membrane Antigen Targeting Ligands via Inductively Coupled Plasma Mass Spectrometry. 61
31714783 2019
268
Photoirradiation after aminolevulinic acid treatment suppresses cancer cell proliferation through the HO-1/p21 pathway. 61
31404677 2019
269
The dietary combination of essential oils and organic acids reduces Salmonella enteritidis in challenged chicks. 61
31393588 2019
270
Calcitonin induces stem cell-like phenotype in prostate cancer cells. 61
31561211 2019
271
Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617. 61
31780798 2019
272
Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate Cancer Cells In-Vitro. 61
31759358 2019
273
Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer. 61
31621030 2019
274
Characterization of HMGB1/2 Interactome in Prostate Cancer by Yeast Two Hybrid Approach: Potential Pathobiological Implications. 61
31694235 2019
275
Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling. 61
31419729 2019
276
Ligand induced dissociation of the AR homodimer precedes AR monomer translocation to the nucleus. 61
31723170 2019
277
Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines. 61
31703454 2019
278
2-Deoxyglycoside Conjugates of Lupane Triterpenoids with High Cytotoxic Activity-Synthesis, Activity, and Pharmacokinetic Profile. 61
31553559 2019
279
Discovery and optimization of 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one derivatives as mTORC1/mTORC2 dual inhibitors. 61
31526911 2019
280
Macroline-Sarpagine Bisindole Alkaloids with Antiproliferative Activity from Alstonia penangiana. 61
31642315 2019
281
A quantitative study of intercellular heterogeneity in gold nanoparticle uptake across multiple cell lines. 61
31691854 2019
282
Design, synthesis and anticancer evaluation of novel 1,3-benzodioxoles and 1,4-benzodioxines. 61
31421253 2019
283
Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26. 61
31745219 2019
284
Eriocalyxin B Induces Apoptosis and Autophagy Involving Akt/Mammalian Target of Rapamycin (mTOR) Pathway in Prostate Cancer Cells. 61
31714902 2019
285
Dual VEGFR-2/PIM-1 kinase inhibition towards surmounting the resistance to antiangiogenic agents via hybrid pyridine and thienopyridine-based scaffolds: Design, synthesis and biological evaluation. 61
31473473 2019
286
Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design, synthesis and evaluation of antitumor cytotoxicity and caspase activation activity. 61
31479984 2019
287
New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition. 61
31536956 2019
288
Overexpression of SOCS3 mediated by adenovirus vector in mouse and human castration-resistant prostate cancer cells increases the sensitivity to NK cells in vitro and in vivo. 61
30607005 2019
289
MicroRNA-143-3p targets pyruvate carboxylase expression and controls proliferation and migration of MDA-MB-231 cells. 61
31697914 2019
290
Betulinic Acid, the first lupane-type triterpenoid isolated via bioactivity-guided fractionation, and identified by spectroscopic analysis from leaves of Nyctanthes arbor-tristis: its potential biological activities in vitro assays. 61
29724132 2019
291
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies. 61
31718684 2019
292
Induction of sub-G0 arrest and apoptosis by seed extract of Moringa peregrina (Forssk.) Fiori in cervical and prostate cancer cell lines. 61
31669164 2019
293
β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells. 61
31771535 2019
294
Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with Therapeutic Potential. 61
31260254 2019
295
Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model. 61
31445229 2019
296
Nanoscale AFM-IR spectroscopic imaging of lipid heterogeneity and effect of irradiation in prostate cancer cells. 61
31300624 2019
297
JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer. 61
31434609 2019
298
Buforin IIb induces androgen-independent prostate cancer cells apoptosis though p53 pathway in vitro. 61
31229626 2019
299
Leelamine Is a Novel Lipogenesis Inhibitor in Prostate Cancer Cells In Vitro and In Vivo. 61
31395683 2019
300
The bispecific anti-CD3 × anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer. 61
30374653 2019
301
Screening, identification of prostate cancer urinary biomarkers and verification of important spots. 61
30610587 2019
302
MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2. 61
31696466 2019
303
3D porous chitosan-alginate scaffold stiffness promotes differential responses in prostate cancer cell lines. 61
31279100 2019
304
Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence. 61
31553876 2019
305
Glucosinolate-Degradation Products as Co-Adjuvant Therapy on Prostate Cancer in Vitro. 61
31600887 2019
306
Molecular signatures associated with prostate cancer cell line (PC-3) exposure to inactivated Zika virus. 61
31653965 2019
307
Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination. 61
31695844 2019
308
Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-β signaling pathway. 61
31465732 2019
309
Discovery, synthesis and molecular substantiation of N-(benzo[d]thiazol-2-yl)-2-hydroxyquinoline-4-carboxamides as anticancer agents. 61
31382059 2019
310
Tyrosine-based asymmetric urea ligand for prostate carcinoma: Tuning biological efficacy through in silico studies. 61
31404798 2019
311
Migration and Invasion Enhancer 1 Is an NF-ĸB-Inducing Gene Enhancing the Cell Proliferation and Invasion Ability of Human Prostate Carcinoma Cells In Vitro and In Vivo. 61
31581708 2019
312
The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway. 61
31448674 2019
313
Identification and characterization of protein phosphorylation in the soluble protein fraction of scallop (Chlamys farreri) byssus. 61
31264161 2019
314
The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers. 61
30632005 2019
315
Structural and biological study of synthesized anthraquinone series of compounds with sulfonamide feature. 61
30489230 2019
316
Strength Development and Strain Localization Behavior of Cemented Paste Backfills Using Portland Cement and Fly Ash. 61
31601013 2019
317
Synthesis of Novel Analogs of Thieno[2,3-d] Pyrimidin-4(3H)-ones as Selective Inhibitors of Cancer Cell Growth. 61
31640194 2019
318
Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery. 61
31271101 2019
319
Identification and characterization of oligomeric proanthocyanidins with significant anti-cancer activity in adzuki beans (Vigna angularis). 61
31687492 2019
320
A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance. 61
31266816 2019
321
Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity. 61
31254921 2019
322
Determination of cell nucleus-to-cytoplasmic ratio using imaging flow cytometry and a combined ultrasound and photoacoustic technique: a comparison study. 61
31625322 2019
323
Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety. 61
31493989 2019
324
Structurally Modified Cyclopenta[b]benzofuran Analogues Isolated from Aglaia perviridis. 61
31621322 2019
325
Exploring New Structural Features of the 18β-Glycyrrhetinic Acid Scaffold for the Inhibition of Anaplastic Lymphoma Kinase. 61
31597403 2019
326
Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study. 61
31103337 2019
327
Peptide-based targeted polymeric nanoparticles for siRNA delivery. 61
31295734 2019
328
Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer. 61
31545228 2019
329
Two new pregnane steroidal glycosides from Cynanchum taihangense. 61
31581856 2019
330
Antiproliferative Activity of Hypericum perforatum, Achillea millefolium, and Aloe vera in Interaction with the Prostatic Activity of CD82. 61
32274398 2019
331
Sulfonamide phenylalanine (SPA) series of analogues as an antibacterial, antifungal, anticancer agents along with p53 tumor suppressor-DNA complex inhibitor - part 1. 61
31547774 2019
332
Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis. 61
31444549 2019
333
CID-6033590 inhibits p38MAPK pathway and induces S-phase cell cycle arrest and apoptosis in DU145 and PC-3 cells. 61
31175925 2019
334
Topological properties and in vitro identification of essential nodes of the Paclitaxel and Vincristine interactomes in PC-3 cells. 61
31783991 2019
335
Water soluble, optically active monofunctional Pd(ii) and Pt(ii) compounds: promising adhesive and antimigratory effects on human prostate PC-3 cancer cells. 61
31482936 2019
336
Interference of Seasonal Variation on the Antimicrobial and Cytotoxic Activities of the Essential Oils from the Leaves of Iryanthera polyneura in the Amazon Rain Forest. 61
31441194 2019
337
Design, synthesis and biological evaluation of new steroidal β-triazoly enones as potent antiproliferative agents. 61
31229507 2019
338
Amide-tethered quinoline-resorcinol conjugates as a new class of HSP90 inhibitors suppressing the growth of prostate cancer cells. 61
31349117 2019
339
Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use. 61
31264168 2019
340
Design and synthesis of phenylpiperazine derivatives as potent anticancer agents for prostate cancer. 61
31148379 2019
341
FENDRR reduces tumor invasiveness in prostate cancer PC-3 cells by targeting CSNK1E. 61
31539119 2019
342
EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway. 61
31599405 2019
343
T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells. 61
31334879 2019
344
Targeted Regulation of miR-26a on PTEN to Affect Proliferation and Apoptosis of Prostate Cancer Cells. 61
31135180 2019
345
Preclinical Evaluation and Pilot Clinical Study of Al18F-PSMA-BCH for Prostate Cancer PET Imaging. 61
30796170 2019
346
Chinese Herbal Medicine Ganoderma tsugae Displays Potential Anti-Cancer Efficacy on Metastatic Prostate Cancer Cells. 61
31500366 2019
347
Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma. 61
31229922 2019
348
Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer. 61
31481527 2019
349
Novel mechanism of endocrine disruption by fungicides through binding to the membrane androgen receptor, ZIP9 (SLC39A9), and antagonizing rapid testosterone induction of the intrinsic apoptotic pathway. 61
31152826 2019
350
Oxime-based 19-nortestosterone-pheophorbide a conjugate: bimodal controlled release concept for PDT. 61
31414695 2019
351
Combination of Proton Therapy and Radionuclide Therapy in Mice: Preclinical Pilot Study at the Paul Scherrer Institute. 61
31480730 2019
352
Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity. 61
31216504 2019
353
Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3Kα Inhibitors. 61
31547116 2019
354
Metal Incorporated g-C₃N₄ Nanosheets as Potential Cytotoxic Agents for Promoting Free Radical Scavenging in Cancer Cell Lines. 61
30961695 2019
355
Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine and quinazoline derivatives as potent antitumor agents. 61
31280016 2019
356
Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo. 61
31548560 2019
357
Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities. 61
31129452 2019
358
Distinct biological responses of metastatic castration resistant prostate cancer cells upon exposure to G-quadruplex interacting naphthalenediimide derivatives. 61
31158753 2019
359
Phenylpropanoids and lignoids from the whole plant of Vaccinium emarginatum and their cytotoxicity against prostate cancer cells. 61
31496280 2019
360
Castanea sativa Mill. Shells Aqueous Extract Exhibits Anticancer Properties Inducing Cytotoxic and Pro-Apoptotic Effects. 61
31546790 2019
361
The effect of curcumin in antitumor photodynamic therapy: In vitro experiments with Caco-2 and PC-3 cancer lines. 61
31100447 2019
362
Inorganic Selenium Induces Nonapoptotic Programmed Cell Death in PC-3 Prostate Cancer Cells Associated with Inhibition of Glycolysis. 61
31513389 2019
363
Apoptotic activity of xanthoquinodin JBIR-99, from Parengyodontium album MEXU 30054, in PC-3 human prostate cancer cells. 61
31433962 2019
364
Gummosin, a sesquiterpene coumarin from Ferula assa-foetida is preferentially cytotoxic to human breast and prostate cancer cell lines. 61
31516858 2019
365
Novel Poly(Adenosine Diphosphate-Ribose) Polymerase (PARP) Inhibitor, AZD2461, Down-Regulates VEGF and Induces Apoptosis in Prostate Cancer Cells 61
31102368 2019
366
Cellulase productivity of Trichoderma reesei mutants developed in Japan varies with varying pH conditions. 61
30975564 2019
367
Synthesis and anticancer activity of some pyrido[2,3-d]pyrimidine derivatives as apoptosis inducers and cyclin-dependent kinase inhibitors. 61
31544523 2019
368
Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients. 61
31132755 2019
369
Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer. 61
31451680 2019
370
SIRT1 Modulates the Sensitivity of Prostate Cancer Cells to Vesicular Stomatitis Virus Oncolysis. 61
31092575 2019
371
MiR-1266 suppresses the growth and metastasis of prostate cancer via targeting PRMT5. 61
31378882 2019
372
Secreted frizzled-related protein 5 suppresses aggressive phenotype and reverses docetaxel resistance in prostate cancer. 61
30787036 2019
373
Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth. 61
31391540 2019
374
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer. 61
31134301 2019
375
In vitro and computational studies showed that perezone inhibits PARP-1 and induces changes in the redox state of K562 cells. 61
31063714 2019
376
Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart. 61
31382362 2019
377
Tumor Cell Behavior in Porous Hydrogels: Effect of Application Technique and Doxorubicin Treatment. 61
31502133 2019
378
Anticancer Activity of Water-Soluble Olsalazine-PAMAM-Dendrimer-Salicylic Acid-Conjugates. 61
31412571 2019
379
Synthesis and cytotoxicity of the conjugates of diterpenoid isosteviol and N-acetyl-D-glucosamine. 61
31402704 2019
380
Comparative evaluation of the new GRPR-antagonist 111 In-SB9 and 111 In-AMBA in prostate cancer models: Implications of in vivo stability. 61
30963606 2019
381
Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells. 61
31399560 2019
382
Cell Responses to Electrical Pulse Stimulation for Anticancer Drug Release. 61
31430890 2019
383
Paederia foetida induces anticancer activity by modulating chromatin modification enzymes and altering pro-inflammatory cytokine gene expression in human prostate cancer cells. 61
31112703 2019
384
Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates. 61
31248772 2019
385
Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression. 61
30613973 2019
386
Isolation and characterization of a novel oligomeric proanthocyanidin with significant anti-cancer activities from grape stems (Vitis vinifera). 61
31427660 2019
387
Bruceadysentoside A, a new pregnane glycoside and others secondary metabolites with cytotoxic activity from brucea antidysenterica J. F. Mill. (simaroubaceae). 61
31434501 2019
388
Cytotoxicity screening of supercritical fluid extracted seaweeds and phenylpropanoids. 61
31004301 2019
389
Achieving the balance: Biphasic effects of genistein on PC-3 cells. 61
31368541 2019
390
Silymarin Enriched Extract (Silybum marianum) Additive Effect on Doxorubicin-Mediated Cytotoxicity in PC-3 Prostate Cancer Cells. 61
31288278 2019
391
Esterified Derivatives of Panaxadiol and Their Inhibitory Effect on HL-60, THP-1, and PC-3 Cell Lines. 61
31298488 2019
392
In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening. 61
31200118 2019
393
Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer. 61
31064850 2019
394
Effects of dihydroartemisinin on HSP70 expression in human prostate cancer PC-3 cells. 61
30972796 2019
395
EGF-activated PI3K/Akt signalling coordinates leucine uptake by regulating LAT3 expression in prostate cancer. 61
31345230 2019
396
Targeting lactate dehydrogenase‑A promotes docetaxel‑induced cytotoxicity predominantly in castration‑resistant prostate cancer cells. 61
31180564 2019
397
Lupane Triterpenoids and New Derivatives as Antiproliferative Agents Against Prostate Cancer Cells. 61
31262911 2019
398
Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer. 61
31340483 2019
399
Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization. 61
30834613 2019
400
New Trisulfated Steroids from the Vietnamese Marine Sponge Halichondria vansoesti and Their PSA Expression and Glucose Uptake Inhibitory Activities. 61
31357591 2019
401
Design, synthesis and biological evaluation of benzimidazole derivatives as novel human Pin1 inhibitors. 61
31103446 2019
402
Ascomylactams A-C, Cytotoxic 12- or 13-Membered-Ring Macrocyclic Alkaloids Isolated from the Mangrove Endophytic Fungus Didymella sp. CYSK-4, and Structure Revisions of Phomapyrrolidones A and C. 61
31251621 2019
403
Synthesis of Usnic Acid Derivatives and Evaluation of Their Antiproliferative Activity against Cancer Cells. 61
31282672 2019
404
A nanodroplet cell processing platform facilitating drug synergy evaluations for anti-cancer treatments. 61
31300742 2019
405
Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin. 61
31251599 2019
406
Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer. 61
31346796 2019
407
An integrated PKD1-dependent signaling network amplifies IRE1 prosurvival signaling. 61
31167779 2019
408
Cytoprotective Compounds Interfere with the Nutraceutical Potential of Bread Supplemented with Green Coffee Beans. 61
31330944 2019
409
Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy. 61
31366895 2019
410
Electrical Impedance Spectroscopy for Characterization of Prostate PC-3 and DU 145 Cancer Cells. 61
31947327 2019
411
The rBC2LCN-positive subpopulation of PC-3 cells exhibits cancer stem-like properties. 61
31133376 2019
412
Characterization of an in vitro model to study the possible role of polyomavirus BK in prostate cancer. 61
30515818 2019
413
Metastatic prostate cancer cells are highly sensitive to 3-bromopyruvic acid. 61
30928407 2019
414
New Insights into the Role of Polybromo-1 in Prostate Cancer. 61
31212728 2019
415
Effect of citrus peel extracts on the cellular quiescence of prostate cancer cells. 61
31169845 2019
416
Modulatory Effect of Selected Dietary Phytochemicals on Delayed Rectifier K+ Current in Human Prostate Cancer Cells. 61
31165179 2019
417
Antitumor effect of a dual cancer-specific oncolytic adenovirus on prostate cancer PC-3 cells. 61
30665692 2019
418
Ectopic expression of CC chemokine receptor 7 promotes prostate cancer cells metastasis via Notch1 signaling. 61
30548287 2019
419
miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis. 61
30582208 2019
420
Downregulated NOX4 underlies a novel inhibitory role of microRNA-137 in prostate cancer. 61
30637800 2019
421
Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer. 61
31196962 2019
422
Paclitaxel resistance and the role of miRNAs in prostate cancer cell lines. 61
30244336 2019
423
Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models. 61
30904813 2019
424
HLA-DQB1 Position 57 Defines Susceptibility to Isolated and Polyglandular Autoimmunity in Adults: Interaction With Gender. 61
30590628 2019
425
2,4-Disubstituted quinazolines targeting breast cancer cells via EGFR-PI3K. 61
30939352 2019
426
Enhanced Allicin Cytotoxicity on HEPG-2 Cells Using Glycyrrhetinic Acid Surface-Decorated Gelatin Nanoparticles. 61
31460232 2019
427
In Vitro and In Vivo Evaluation of Antitumor Activity of Ligustrum robustum, A Chinese Herbal Tea. 61
29790063 2019
428
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. 61
30933831 2019
429
The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells. 61
31081051 2019
430
Characterization of H2S releasing properties of various H2S donors utilizing microplate cover-based colorimetric assay. 61
30946806 2019
431
New analogs of SYA013 as sigma-2 ligands with anticancer activity. 61
30987780 2019
432
Design, synthesis, and biological evaluation of tetrahydroisoquinoline-based diaryl urea derivatives for suppressing VEGFR-2 signaling. 61
30531369 2019
433
Dammarane-type triterpenoids from the stem of Ziziphus glaziovii Warm. (Rhamnaceae). 61
30965192 2019
434
Suppression of STAT3 Phosphorylation and RelA/p65 Acetylation Mediated by MicroRNA134 Plays a Pivotal Role in the Apoptotic Effect of Lambertianic Acid. 61
31248140 2019
435
Comparative Analysis of Lycopene Content from Different Tomato-Based Food Products on the Cellular Activity of Prostate Cancer Cell Lines. 61
31185698 2019
436
Photoradiosynthesis of 68Ga-Labeled HBED-CC-Azepin-MetMAb for Immuno-PET of c-MET Receptors. 61
31117346 2019
437
New Ophiobolin Derivatives from the Marine Fungus Aspergillus flocculosus and Their Cytotoxicities against Cancer Cells. 61
31212583 2019
438
Design, Synthesis and Biological Evaluation of a New Series of 1-Aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea Derivatives as Antiproliferative Agents. 61
31167363 2019
439
Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics. 61
31002345 2019
440
Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation. 61
30921757 2019
441
Synthesis and Evaluation of Novel Pyrazole Ethandiamide Compounds as Inhibitors of Human THP-1 Monocytic Cell Neurotoxicity. 61
31261948 2019
442
Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (type II). 61
31203805 2019
443
Antimicrobial property and antiproliferative activity of Centaurea babylonica (L.) L. on human carcinomas and cervical cancer cell lines. 61
31232061 2019
444
Production of highly thermo-tolerant laccase from novel thermophilic bacterium Bacillus sp. PC-3 and its application in functionalization of chitosan film. 61
30573384 2019
445
2-Methyl-versiquinazoline C, a new fumiquinazoline-type alkaloid from the fungus Aspergillus flavipes PJ03-11. 61
29693414 2019
446
Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway. 61
30889629 2019
447
Discovery of 18F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions. 61
30389823 2019
448
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells. 61
31060628 2019
449
MicroRNA‑302a upregulation mediates chemo‑resistance in prostate cancer cells. 61
30942454 2019
450
Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition. 61
31061414 2019
451
Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands. 61
31260881 2019
452
Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer. 61
30663084 2019
453
Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells. 61
30894404 2019
454
Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells. 61
31126091 2019
455
TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer. 61
30888515 2019
456
Effect of docetaxel on the regulation of proliferation and apoptosis of human prostate cancer cells. 61
30864701 2019
457
Estrogen receptor β suppresses inflammation and the progression of prostate cancer. 61
30864712 2019
458
Anti-Cancer Activity of Novel Dihydrotestosterone-Derived Ring A-Condensed Pyrazoles on Androgen Non-Responsive Prostate Cancer Cell Lines. 61
31052484 2019
459
Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells. 61
30654342 2019
460
Long noncoding RNA LINC00662 functions as miRNA sponge to promote the prostate cancer tumorigenesis through targeting miR-34a. 61
31114993 2019
461
MicroRNA‑9 suppresses human prostate cancer cell viability, invasion and migration via modulation of mitogen‑activated protein kinase kinase kinase 3 expression. 61
30896820 2019
462
Plant origin authentication of Sonoran Desert propolis: an antiproliferative propolis from a semi-arid region. 61
31069518 2019
463
Polydopamine-decorated tobacco mosaic virus for photoacoustic/magnetic resonance bimodal imaging and photothermal cancer therapy. 61
31066418 2019
464
Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction. 61
30802707 2019
465
Development of Bispecific NT-PSMA Heterodimer for Prostate Cancer Imaging: A Potential Approach to Address Tumor Heterogeneity. 61
31034212 2019
466
Accurate intracellular and in vivo temperature sensing based on CuInS2/ZnS QD micelles. 61
32255086 2019
467
The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers. 61
30904591 2019
468
Kenalactams A-E, Polyene Macrolactams Isolated from Nocardiopsis CG3. 61
31021629 2019
469
LncRNA UCA1 acts as a sponge of miR-204 to up-regulate CXCR4 expression and promote prostate cancer progression. 61
30940776 2019
470
Dopamine receptor antagonists induce differentiation of PC-3 human prostate cancer cell-derived cancer stem cell-like cells. 61
30816566 2019
471
The effect of the overexpression of miR-490 on the biological function of prostate cancer cell PC-3. 61
31424678 2019
472
Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway. 61
30944622 2019
473
Piperine blocks voltage gated K+ current and inhibits proliferation in androgen sensitive and insensitive human prostate cancer cell lines. 61
31047869 2019
474
Two new physalin derivatives from Physalis alkekengi L. var. franchetii (Mast.) Makino. 61
31140313 2019
475
Heavy Metals in Suspended Particulate Matter of the Zhujiang River, Southwest China: Contents, Sources, and Health Risks. 61
31137629 2019
476
Multiphoton fluorescence lifetime imaging microscopy (FLIM) and super-resolution fluorescence imaging with a supramolecular biopolymer for the controlled tagging of polysaccharides. 61
31046042 2019
477
Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression. 61
31052319 2019
478
miR-500 promotes cell proliferation by directly targetting LRP1B in prostate cancer. 61
30877185 2019
479
Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells. 61
30569541 2019
480
MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A. 61
30302800 2019
481
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer. 61
30647103 2019
482
Cell-based evidence regarding the role of FSH in prostate cancer. 61
30611646 2019
483
Synthesis of Pyridine-Dicarboxamide-Cyclohexanone Derivatives: Anticancer and α-Glucosidase Inhibitory Activities and In Silico Study. 61
30987350 2019
484
Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts. 61
31022918 2019
485
Endoplasmic reticulum stress, autophagic and apoptotic cell death, and immune activation by a natural triterpenoid in human prostate cancer cells. 61
30378157 2019
486
Dokdolipids A-C, Hydroxylated Rhamnolipids from the Marine-Derived Actinomycete Actinoalloteichus hymeniacidonis. 61
31010028 2019
487
Antiproliferative and antibiofilm potentials of endolichenic fungi associated with the lichen Nephroma laevigatum. 61
30597735 2019
488
Synthesis and antiproliferative evaluation of new zampanolide mimics. 61
30924817 2019
489
Conolodinines A-D, Aspidosperma- Aspidosperma Bisindole Alkaloids with Antiproliferative Activity from Tabernaemontana corymbosa. 61
30869890 2019
490
A Useful Synthesis of 2-Acylamino-1,3,4-oxadiazoles from Acylthiosemicarbazides Using Potassium Iodate and the Discovery of New Antibacterial Compounds. 61
30988267 2019
491
Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors⁻Indocyanine Dyes Conjugates as Targeted Antitumor Agents. 61
30974737 2019
492
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells. 61
30844609 2019
493
Cytotoxic constituents from Penicillium concentricum, an endophytic fungus from Trichocolea tomentella. 61
30688672 2019
494
Facile development, characterization, and evaluation of novel bicalutamide loaded pH-sensitive mesoporous silica nanoparticles for enhanced prostate cancer therapy. 61
30582382 2019
495
Identification of Further Components of an Anticancer Defense System Composed of Small Molecules Present in the Serum. 61
30648878 2019
496
Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity. 61
30653817 2019
497
CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance. 61
30776468 2019
498
Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice. 61
30779980 2019
499
Identification of dehydroxy isoquine and isotebuquine as promising anticancer agents targeting K+ channel. 61
30570823 2019
500
Oxytrodiflavanone A and Oxytrochalcoflavanones A,B: New Biflavonoids from Oxytropis chiliophylla. 61
31013944 2019
501
Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors. 61
30879863 2019
502
Click chemistry-based synthesis and cytotoxic activity evaluation of 4α-triazole acetate podophyllotoxin derivatives. 61
30394007 2019
503
Purines Change at Acupoints along the Pericardium Meridian in Healthy and Myocardial Ischemic Rats. 61
30264268 2019
504
Synthesis, anti-proliferative and apoptosis-inducing studies of palladacycles containing a diphosphine and a Sn,As-based chelate ligand. 61
30838370 2019
505
Precise Modeling of the Protective Effects of Quercetin against Mycotoxin via System Identification with Neural Networks. 61
30965553 2019
506
Synthesis, computational quantum chemical study, in silico ADMET and molecular docking analysis, in vitro biological evaluation of a novel sulfur heterocyclic thiophene derivative containing 1,2,3-triazole and pyridine moieties as a potential human topoisomerase IIα inhibiting anticancer agent. 61
30731361 2019
507
The Anti-Proliferation, Cycle Arrest and Apoptotic Inducing Activity of Peperomin E on Prostate Cancer PC-3 Cell Line. 61
30991627 2019
508
Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells. 61
31023247 2019
509
Semisynthetic aurones inhibit tubulin polymerization at the colchicine-binding site and repress PC-3 tumor xenografts in nude mice and myc-induced T-ALL in zebrafish. 61
31015569 2019
510
Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2). 61
31026254 2019
511
Cytotoxic Prenylated Xanthones from the Leaves of Garcinia bracteata. 61
30650454 2019
512
Stereocontrolled Synthesis of Bispirooxindole-Based Hexahydroxanthones with Five Contiguous Stereocenters. 61
30925061 2019
513
ABT-737 and erufosine combination against castration-resistant prostate cancer: a promising but cell-type specific response associated with the modulation of anti-apoptotic signaling. 61
30557204 2019
514
Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt. 61
30915739 2019
515
The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro. 61
30886380 2019
516
Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoring. 61
30858765 2019
517
Calcilytics inhibit the proliferation and migration of human prostate cancer PC-3 cells. 61
30808588 2019
518
Ent-Dihydrotucumanoic acid promotes apoptosis in PC-3 human prostate cancer cells. 61
30942164 2019
519
Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer. 61
30580153 2019
520
Overexpressed LRIG3 gene ameliorates prostate cancer through suppression of cell invasion and migration. 61
30412760 2019
521
Sox7 negatively regulates prostate-specific membrane antigen (PSMA) expression through PSMA-enhancer. 61
30488457 2019
522
Chemical composition, antioxidant, antimicrobial and anticancer activities of the essential oil from the rhizomes of Zingiber striolatum Diels. 61
30908095 2019
523
Structure-Based Design of Novel Benzimidazole Derivatives as Pin1 Inhibitors. 61
30934730 2019
524
Stereocontrolled [3+2] Cycloaddition of Donor-Acceptor Cyclopropanes to Iminooxindoles: Access to Spiro[oxindole-3,2'-pyrrolidines]. 61
30735387 2019
525
MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression. 61
30543885 2019
526
Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agents. 61
30343204 2019
527
Fomes fomentarius Ethanol Extract Exerts Inhibition of Cell Growth and Motility Induction of Apoptosis via Targeting AKT in Human Breast Cancer MDA-MB-231 Cells. 61
30845749 2019
528
Quantitative immunohistochemical assay with novel digital immunostaining for comparisons of PD-L1 antibodies. 61
30847180 2019
529
Antidiarrheal, Analgesic, and Anthelmintic Activities of Honeys in the Sundarbans Mangrove Forest, Bangladesh. 61
31008096 2019
530
Design, Synthesis, and Molecular Docking Study of Novel Heterocycles Incorporating 1,3,4-Thiadiazole Moiety as Potential Antimicrobial and Anticancer Agents. 61
30889918 2019
531
CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling. 61
30935014 2019
532
Localization of 99mTc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses. 61
30897789 2019
533
[Citron Rho-interacting serine/threonine kinase knockdown suppresses prostate cancer cell proliferation and metastasis by blocking Hippo-YAP pathway]. 61
31068310 2019
534
Quantification of Cell Death Using an Impedance-Based Microfluidic Device. 61
30793881 2019
535
In vitro antioxidant and antiproliferative effect of the extracts of Ephedra chilensis K Presl aerial parts. 61
30832627 2019
536
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair. 61
30871262 2019
537
Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells. 61
30797819 2019
538
The determination of the potential anticancer effects of Coriandrum sativum in PC-3 and LNCaP prostate cancer cell lines. 61
30417420 2019
539
RAD9A promotes metastatic phenotypes through transcriptional regulation of anterior gradient 2 (AGR2). 61
30295739 2019
540
Correlation of SOX9 and NM23 genes with the incidence and prognosis of prostate cancer. 61
30675295 2019
541
The BET-inhibitor PFI-1 diminishes AR/AR-V7 signaling in prostate cancer cells. 61
29934670 2019
542
αvβ3 Integrin Mediates Radioresistance of Prostate Cancer Cells through Regulation of Survivin. 61
30266752 2019
543
Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis. 61
30177837 2019
544
Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer. 61
30345530 2019
545
Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis. 61
30591422 2019
546
Cellular Refractive Index Comparison of Various Prostate Cancer and Noncancerous Cell Lines via Photonic-Crystal Biosensor. 61
32313355 2019
547
SWATH proteomic profiling of prostate cancer cells identifies NUSAP1 as a potential molecular target for Galiellalactone. 61
30626528 2019
548
Hypoxia Patterns in Primary and Metastatic Prostate Cancer Environments. 61
30639975 2019
549
Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents. 61
30508794 2019
550
Chlorambucil Conjugated Ugi Dendrimers with PAMAM-NH₂ Core and Evaluation of Their Anticancer Activity. 61
30717083 2019
551
miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2. 61
29471894 2019
552
Butyl benzyl phthalate promotes prostate cancer cell proliferation through miR-34a downregulation. 61
30243731 2019
553
Anti-tumor activity and the mechanism of a green tea (Camellia sinensis) polysaccharide on prostate cancer. 61
30342140 2019
554
Iterative unsupervised domain adaptation for generalized cell detection from brightfield z-stacks. 61
30767778 2019
555
In vivo comparison of the proangiogenic properties of chlordecone and three of its dechlorinated derivatives formed by in situ chemical reduction. 61
30710326 2019
556
Development of Novel Anticancer Agents with a Scaffold of Tetrahydropyrido[4,3-d]pyrimidine-2,4-dione. 61
30783502 2019
557
An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity. 61
30585173 2019
558
Bioactive scalemic caged xanthones from the leaves of Garcinia bracteata. 61
30396061 2019
559
Development of alkyl glycerone phosphate synthase inhibitors: Structure-activity relationship and effects on ether lipids and epithelial-mesenchymal transition in cancer cells. 61
30576903 2019
560
The human oncogene SCL/TAL1 interrupting locus (STIL) promotes tumor growth through MAPK/ERK, PI3K/Akt and AMPK pathways in prostate cancer. 61
30453068 2019
561
Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer. 61
30554119 2019
562
DGAT1 Inhibitor Suppresses Prostate Tumor Growth and Migration by Regulating Intracellular Lipids and Non-Centrosomal MTOC Protein GM130. 61
30816200 2019
563
Effect of Compatibility on the Foaming Behavior of Injection Molded Polypropylene and Polycarbonate Blend Parts. 61
30960284 2019
564
Design, synthesis and biological evaluation of novel 7-amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-aminotetrazolo[1,5-f]pteridinone derivative as potent antitumor agents. 61
30572179 2019
565
Bioactive staurosporine derivatives from the Streptomyces sp. NB-A13. 61
30268972 2019
566
Synthesis of new chalcone-based homoserine lactones and their antiproliferative activity evaluation. 61
30553142 2019
567
Cytotoxic triterpenoid saponins from the root of Anemone tomentosa (Maxim.) Pei. 61
30810364 2019
568
MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3. 61
30483762 2019
569
miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition. 61
30717752 2019
570
HIF1α promotes prostate cancer progression by increasing ATG5 expression. 61
31700698 2019
571
Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells. 61
31099011 2019
572
Extracellular Electrophysiology in the Prostate Cancer Cell Model PC-3. 61
30609788 2019
573
Synergistic Effects of Nobiletin and Sorafenib Combination on Metastatic Prostate Cancer Cells. 61
31037974 2019
574
[Role of limb-bud and heart development expression in prostate cancer]. 61
32212501 2019
575
The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer. 61
31819645 2019
576
Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells. 61
31210839 2019
577
Evaluation of A Novel GLP-1R Ligand for PET Imaging of Prostate Cancer. 61
30068284 2019
578
Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer. 61
30828077 2019
579
Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents. 61
30482547 2019
580
Targeting prostate cancer cell proliferation, stemness and metastatic potential using Costus speciosus derived phytochemicals. 61
31105862 2019
581
Galectin-9 induces atypical ubiquitination leading to cell death in PC-3 prostate cancer cells. 61
30383222 2019
582
Herceptin-conjugated liposomes co-loaded with doxorubicin and simvastatin in targeted prostate cancer therapy. 61
30972160 2019
583
Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13. 61
30899277 2019
584
Immuno-PET imaging of VEGFR-2 expression in prostate cancer with 89Zr-labeled ramucirumab. 61
31598404 2019
585
SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway. 61
31497238 2019
586
In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer. 61
31032634 2019
587
MCT4 promotes cell proliferation and invasion of castration-resistant prostate cancer PC-3 cell line. 61
31217781 2019
588
Inhibition of Prostate Cancer Cells by 4,5-Dicaffeoylquinic Acid through Cell Cycle Arrest. 61
31263600 2019
589
Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer. 61
31205531 2019
590
CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p. 61
31118688 2019
591
Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer. 61
31920642 2019
592
miR-106a contributes to prostate carcinoma progression through PTEN. 61
30655902 2019
593
Tumor-Specific S/G2-Phase Cell Cycle Arrest of Cancer Cells by Methionine Restriction. 61
30725407 2019
594
Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells. 61
30972064 2019
595
PC-3-Derived Exosomes Inhibit Osteoclast Differentiation by Downregulating miR-214 and Blocking NF-κB Signaling Pathway. 61
31058194 2019
596
Pirfenidone, an Anti-Fibrotic Drug, Suppresses the Growth of Human Prostate Cancer Cells by Inducing G₁ Cell Cycle Arrest. 61
30621175 2019
597
The anti-apoptotic proteins NAF-1 and iASPP interact to drive apoptosis in cancer cells. 61
30774867 2019
598
Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives. 61
30521816 2019
599
Synthesis and SAR of novel capsazepine analogs with significant anti-cancer effects in multiple cancer types. 61
30528162 2019
600
MicroRNA-4719 and microRNA-6756-5p Correlate with Castration-Resistant Prostate Cancer Progression through Interleukin-24 Regulation. 61
30669553 2019
601
Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cells. 61
30680044 2019
602
Long non-coding RNA CCAT1/miR-148a/PKCζ prevents cell migration of prostate cancer by altering macrophage polarization. 61
30221381 2019
603
Metabolic signature of extracellular vesicles depends on the cell culture conditions. 61
31007875 2019
604
Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers. 61
31417252 2019
605
Cross Sectional Study and Risk Factors Analysis of Francisella tularensis in Soil Samples in Punjab Province of Pakistan. 61
31024860 2019
606
Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity. 61
30657049 2019
607
Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer. 61
31118572 2019
608
Synthesis and Biological Evaluation of Novel 4,5,6,7-Tetrahydrobenzo[D]-Thiazol-2- Yl Derivatives Derived from Dimedone with Anti-Tumor, C-Met, Tyrosine Kinase and Pim-1 Inhibitions. 61
31038076 2019
609
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling. 61
31317026 2019
610
Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue. 61
30775647 2019
611
The Combination of Metformin and Valproic Acid Has a Greater Anti-tumoral Effect on Prostate Cancer Growth In Vivo than Either Drug Alone. 61
30587609 2019
612
Bioactive contents, In vitro antiradical, antimicrobial and cytotoxic properties of rhubarb (Rheum ribes L.) extracts. 61
30663386 2019
613
A pair of new enantiomers of xanthones from the stems and leaves of Cratoxylum cochinchinense. 61
30976295 2019
614
Evaluating the biological properties of synthetic 4-nitrophenyl functionalized benzofuran derivatives with telomeric DNA binding and antiproliferative activities. 61
30261256 2019
615
Synthesis and Evaluation of 18F-Labeled Peptide for Gonadotropin-Releasing Hormone Receptor Imaging. 61
30983920 2019
616
Carvacrol Induced Program Cell Death and Cell Cycle Arrest in Androgen-Independent Human Prostate Cancer Cells via Inhibition of Notch Signaling. 61
31364516 2019
617
Antitumoral and Anticholinesterasic Activities of the Seven Species from Rubiaceae. 61
30747062 2019
618
Cytotoxic and Apoptotic Activity of Majoranolide from Mezilaurus crassiramea on HL-60 Leukemia Cells. 61
30941193 2019
619
In-vitro Morphological Assessment of Apoptosis Induced by Nimbolide; A Limonoid from Azadirachta Indica (Neem Tree). 61
31531067 2019
620
A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer. 61
30863051 2019
621
Cytotoxic Activity of Thirteen Endemic and Rare Plants from Chaharmahal and Bakhtiari Province in Iran. 61
32184857 2019
622
Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents. 61
31355179 2019
623
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells. 61
30669516 2019
624
Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells. 61
31083670 2019
625
UPLC-ESI-PDA-Msn Profiling Of Phenolics Involved In Biological Activities Of The Medicinal Plant Halocnemum Strobilaceum (Pall.). 61
31089377 2019
626
The conjugates of forky peptides and nonsteroidal anti-inflammatory drugs (NSAID) self-assemble into supramolecular hydrogels for prostate cancer-specific drug delivery. 61
32254734 2019
627
In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties. 61
31566140 2019
628
Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy. 61
31686814 2019
629
Berberine as Source of Antiproliferative Hybrid Compounds: In Vitro Antiproliferative Activity and Quantitative Structure-activity Relationship. 61
31960788 2019
630
Pim-2 Cooperates with Downstream Factor XIAP to Inhibit Apoptosis and Intensify Malignant Grade in Prostate Cancer. 61
29124675 2019
631
Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice. 61
30880982 2019
632
MiR-1299 functions as a tumor suppressor to inhibit the proliferation and metastasis of prostate cancer by targeting NEK2. 61
30720160 2019
633
Prostate cancer cell growth characteristics in serum and prostate-conditioned media from moderate-intensity exercise-trained healthy and tumor-bearing rats. 61
31105994 2019
634
Cytotoxic xanthones from the roots of Mesua ferrea L. 61
30368220 2019
635
Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer. 61
31694481 2019
636
Design, Synthesis and Biological Evaluation of 4-Aryl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one Derivatives as a PI3Kα Inhibitor. 61
31155575 2019
637
Development of Promising Thiopyrimidine-Based Anti-cancer and Antimicrobial Agents: Synthesis and QSAR Analysis. 61
29600761 2019
638
Tumor targeting with DGEA peptide ligands: a new aromatic peptide amphiphile for imaging cancers. 61
30617356 2019
639
Synthesis of D-Ring Annulated Pyridosteroids from β-Formyl Enamides and Their Biological Evaluations. 61
30576125 2019
640
New depsidone and dichromone from the stems of Garcinia paucinervis with antiproliferative activity. 61
30182180 2019
641
Induction of apoptosis and modulation of homologous recombination DNA repair pathway in prostate cancer cells by the combination of AZD2461 and valproic acid. 61
31423128 2019
642
Unfolded Protein Response is Involved in Trans-Platinum (II) Complex-Induced Apoptosis in Prostate Cancer Cells via ROS Accumulation. 61
30963984 2019
643
Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway. 61
30482548 2019
644
Muscadine grape skin extract inhibits prostate cancer cells by inducing cell-cycle arrest, and decreasing migration through heat shock protein 40. 61
30705983 2019
645
Kaempferol Promotes Apoptosis While Inhibiting Cell Proliferation via Androgen-Dependent Pathway and Suppressing Vasculogenic Mimicry and Invasion in Prostate Cancer. 61
31871879 2019
646
Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions. 61
30663693 2019
647
Precooling, Exertional Heatstroke Risk Factors, and Postexercise Cooling Rates. 61
30579372 2019
648
Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains. 61
30836914 2019
649
[Lipid metabolism study of sodium norcantharidate in LO2 hepatocytes based on lipidomics]. 61
30868827 2019
650
Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling. 61
31534537 2019
651
Naringenin Attenuated Prostate Cancer Invasion via Reversal of Epithelial-to-Mesenchymal Transition and Inhibited uPA Activity. 61
30504386 2018
652
Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells. 61
30541589 2018
653
Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer. 61
30558664 2018
654
Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells. 61
30575899 2018
655
Repurposing antitubercular agent isoniazid for treatment of prostate cancer. 61
30468220 2018
656
A novel selenonucleoside suppresses tumor growth by targeting Skp2 degradation in paclitaxel-resistant prostate cancer. 61
30292755 2018
657
Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells. 61
30488937 2018
658
Addressable TiO2 Nanotubes Functionalized Paper-Based Cyto-Sensor with Photocontrollable Switch for Highly-Efficient Evaluating Surface Protein Expressions of Cancer Cells. 61
30277055 2018
659
Distribution, Sources, and Water Quality Assessment of Dissolved Heavy Metals in the Jiulongjiang River Water, Southeast China. 61
30563145 2018
660
Synthesis and in vitro antitumor evaluation of some new thiophenes and thieno[2,3-d]pyrimidine derivatives. 61
30248510 2018
661
4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles. 61
30433782 2018
662
Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for 64Cu-Based PET Imaging. 61
30376344 2018
663
Optical study of chemotherapy efficiency in cancer treatment via intracellular structural disorder analysis using partial wave spectroscopy. 61
29869394 2018
664
A novel antimicrobial peptide, Ranatuerin-2PLx, showing therapeutic potential in inhibiting proliferation of cancer cells. 61
30279210 2018
665
Multifunctional antioxidant nanoliposome-mediated delivery of PTEN plasmids restore the expression of tumor suppressor protein and induce apoptosis in prostate cancer cells. 61
30194716 2018
666
Low Molecular Weight Mannogalactofucans Derived from Undaria pinnatifida Induce Apoptotic Death of Human Prostate Cancer Cells In Vitro and In Vivo. 61
30159630 2018
667
Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study. 61
29455554 2018
668
A stent film of paclitaxel presenting extreme accumulation of paclitaxel in tumor tissue and excellent antitumor efficacy after implantation beneath the subcutaneous tumor xenograft in mice. 61
30267754 2018
669
Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-d]pyrimidine scaffold. 61
29482389 2018
670
[Data-mining-revealed Regularities of Application of Meridian Acupoints for Coronary Heart Disease in Ancient Chinese Medical Literature]. 61
30585460 2018
671
Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells. 61
30272272 2018
672
Retraction Note: Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling. 61
30587247 2018
673
Potential of piperine in modulation of voltage-gated K+ current and its influences on cell cycle arrest and apoptosis in human prostate cancer cells. 61
30575945 2018
674
Synthesis and antiproliferative activity of 17-[1',2',3']-selenadiazolylpregnenolone compounds. 61
30296550 2018
675
In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer. 61
29556947 2018
676
Volatile Profiling, Insecticidal, Antibacterial and Antiproliferative Properties of the Essential Oils of Bursera glabrifolia Leaves. 61
30187618 2018
677
[Expression of forkhead transcription factor O4 in prostate cancer and its effect on prostate cancer cell invasion]. 61
30643063 2018
678
[MCT4 reduces glucose metabolism and promotes apoptosis of prostate cancer cells]. 61
32212469 2018
679
Glutathione/pH-responsive nanosponges enhance strigolactone delivery to prostate cancer cells. 61
30533197 2018
680
Muscarinic acetylcholine receptor M1 mediates prostate cancer cell migration and invasion through hedgehog signaling. 61
30027929 2018
681
O-Aminoalkyl-O-Trimethyl-2,3-Dehydrosilybins: Synthesis and In Vitro Effects Towards Prostate Cancer Cells. 61
30501133 2018
682
Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo. 61
30419852 2018
683
Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis. 61
30098000 2018
684
Effects of 3-butenyl isothiocyanate on phenotypically different prostate cancer cells. 61
30226593 2018
685
PSMA Antibody-Conjugated Pentablock Copolymer Nanomicellar Formulation for Targeted Delivery to Prostate Cancer. 61
30151731 2018
686
Cytotoxicity of AMANTADIG - a semisynthetic digitoxigenin derivative - alone and in combination with docetaxel in human hormone-refractory prostate cancer cells and its effect on Na+/K+-ATPase inhibition. 61
30107342 2018
687
Arctigenin shows preferential cytotoxicity to acidity-tolerant prostate carcinoma PC-3 cells through ROS-mediated mitochondrial damage and the inhibition of PI3K/Akt/mTOR pathway. 61
30333093 2018
688
Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo. 61
30542512 2018
689
A novel role and mechanism of cystic fibrosis transmembrane conductance regulator in bisphenol A-induced prostate cancer. 61
30485539 2018
690
Glucose-installed biodegradable polymeric micelles for cancer-targeted drug delivery system: synthesis, characterization and in vitro evaluation. 61
30506149 2018
691
Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells. 61
30405791 2018
692
Synthesis of Triazole-Substituted Quinazoline Hybrids for Anticancer Activity and a Lead Compound as the EGFR Blocker and ROS Inducer Agent. 61
30556027 2018
693
Synthesis and Biological Evaluation of Phaeosphaeride A Derivatives as Antitumor Agents. 61
30469343 2018
694
Kinase Inhibitory Activities and Molecular Docking of a Novel Series of Anticancer Pyrazole Derivatives. 61
30477238 2018
695
Monolayer grafting of aminosilane on magnetic nanoparticles: An efficient approach for targeted drug delivery system. 61
29940324 2018
696
2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer. 61
30226607 2018
697
MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line. 61
30400755 2018
698
Direct Transfection of Fatty Acid Conjugated siRNAs and Knockdown of the Glucose-Regulated Chaperones in Prostate Cancer Cells. 61
30235926 2018
699
Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade. 61
30226591 2018
700
Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties. 61
30187047 2018
701
Clickable conjugates of bile acids and nucleosides: Synthesis, characterization, in vitro anticancer and antituberculosis studies. 61
30236620 2018
702
Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery. 61
30017961 2018
703
7,8-Dihydroxy-3-arylcoumarin Induces Cell Death Through S-Phase Arrest in MDA-MB-231 Breast Cancer Cells. 61
30396923 2018
704
GC-MS Characterization of Volatile Flavor Compounds in Stinky Tofu Brine by Optimization of Headspace Solid-Phase Microextraction Conditions. 61
30513662 2018
705
Highly Cancer Selective Antiproliferative Activity of Natural Prenylated Flavonoids. 61
30423918 2018
706
Synthesis and anticancer activity of novel rapamycin C-28 containing triazole moiety compounds. 61
30357890 2018
707
Synthesis and cytotoxic activity of 4-O-β-D-galactopyranosyl derivatives of phenolic acids esters. 61
28920447 2018
708
Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines. 61
30453545 2018
709
Consistent head up cardiopulmonary resuscitation haemodynamics are observed across porcine and human cadaver translational models. 61
29702188 2018
710
Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer. 61
30498970 2018
711
Apoptosis Induction of Agave lechuguilla Torrey Extract on Human Lung Adenocarcinoma Cells (SK-LU-1). 61
30486412 2018
712
18F‑alfatide positron emission tomography may predict anti‑angiogenic responses. 61
30226599 2018
713
The impact of TRAIL on proliferation of secretory prostate cancer PC-3 cell and LMO2 gene expression. 61
30468458 2018
714
Preliminary evaluation of a novel 18F-labeled PARP-1 ligand for PET imaging of PARP-1 expression in prostate cancer. 61
30195072 2018
715
Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12. 61
29493296 2018
716
Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents. 61
30387018 2018
717
Structure-based assessment and network analysis of targeting 14-3-3 proteins in prostate cancer. 61
30382885 2018
718
Cordyceps sinensis Promotes the Growth of Prostate Cancer Cells. 61
30273008 2018
719
Conjugates of 17-substituted testosterone and epitestosterone with pyropheophorbide a differing in the length of linkers. 61
30033342 2018
720
Correlation between DEC1/DEC2 and epithelial‑mesenchymal transition in human prostate cancer PC‑3 cells. 61
30106153 2018
721
Zinc enhances chemosensitivity to paclitaxel in PC‑3 prostate cancer cells. 61
30106439 2018
722
Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents. 61
30228001 2018
723
A natural molecule, urolithin A, downregulates androgen receptor activation and suppresses growth of prostate cancer. 61
30069922 2018
724
Parallel study on protein O-GlcNAcylation in prostate cancer cell with a sensitive microarray biochip. 61
30086259 2018
725
LPA1/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer. 61
30053596 2018
726
Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors. 61
30253887 2018
727
AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling. 61
30139661 2018
728
Cymbopogon citratus and Cymbopogon giganteus essential oils have cytotoxic effects on tumor cell cultures. Identification of citral as a new putative anti-proliferative molecule. 61
29501481 2018
729
Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases. 61
29966873 2018
730
N'-[(E)-Arylidene]-2-(2,3-dihydro-3-oxo-4H-1,4-benzoxazin-4-yl)-acetohydrazides: Synthesis and Evaluation of Caspase Activation Activity and Cytotoxicity. 61
30054973 2018
731
Synthesis, characterization, DNA/HSA interactions and in vitro cytotoxic activities of two novel water-soluble copper(II) complexes with 1,3,5-triazine derivative ligand and amino acids. 61
30033272 2018
732
PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates. 61
30347770 2018
733
Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT1A Receptor Ligands. 61
30347827 2018
734
Peptide-Functionalized Hydrogel Cubes for Active Tumor Cell Targeting. 61
30169033 2018
735
Strategic Pentablock Copolymer Nanomicellar Formulation for Paclitaxel Delivery System. 61
30112614 2018
736
The effects of habitual foot strike patterns on Achilles tendon loading in female runners. 61
30243212 2018
737
Troglitazone inhibits the migration and invasion of PC-3 human prostate cancer cells by upregulating E-cadherin and glutathione peroxidase 3. 61
30250621 2018
738
Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity. 61
30153964 2018
739
Pharmacomodulation on Gold-NHC complexes for anticancer applications - is lipophilicity the key point? 61
30099254 2018
740
Ultrasound‑targeted microbubble destruction‑mediated miR‑205 enhances cisplatin cytotoxicity in prostate cancer cells. 61
30066866 2018
741
Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines. 61
30193584 2018
742
Anticancer mechanism of Sinapic acid in PC-3 and LNCaP human prostate cancer cell lines. 61
29792952 2018
743
Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents. 61
30165345 2018
744
5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer. 61
30189396 2018
745
SERS-Based Quantification of Biomarker Expression at the Single Cell Level Enabled by Gold Nanostars and Truncated Aptamers. 61
30110153 2018
746
Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3. 61
30176898 2018
747
Medermycin-Type Naphthoquinones from the Marine-Derived Streptomyces sp. XMA39. 61
30209946 2018
748
Synthesis and Antiproliferative Activity of New Cyclodiprenyl Phenols against Select Cancer Cell Lines. 61
30213053 2018
749
Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents. 61
30193221 2018
750
Enhanced capture and release of circulating tumor cells using hollow glass microspheres with a nanostructured surface. 61
30160287 2018
751
Enhanced Photodynamic Anticancer Activities of Multifunctional Magnetic Nanoparticles (Fe₃O₄) Conjugated with Chlorin e6 and Folic Acid in Prostate and Breast Cancer Cells. 61
30217046 2018
752
Amino-Substituted 2,2'-Bipyridine Ligands as Fluorescent Indicators for ZnII and Applications for Fluorescence Imaging of Prostate Cells. 61
30051526 2018
753
Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells. 61
29906613 2018
754
Two New Chromone Glycosides from the Roots of Saposhnikovia divaricata. 61
29987893 2018
755
Histone Methyltransferase Setd7 Regulates Nrf2 Signaling Pathway by Phenethyl Isothiocyanate and Ursolic Acid in Human Prostate Cancer Cells. 61
29383876 2018
756
[Design, synthesis and antiproliferative activity in cancer cells of novel dihydropyrazolyl and pyrazolyl artemisinin-phenyl ethers]. 61
30347929 2018
757
Design, Synthesis, and in Vitro and in Vivo Evaluation of High Affinity and Specificity Near-Infrared Fluorescent Bombesin Antagonists for Tumor Imaging. 61
30111088 2018
758
Bakuchiol exhibits anti-metastasis activity through NF-κB cross-talk signaling with AR and ERβ in androgen-independent prostate cancer cells PC-3. 61
30236540 2018
759
Novel selenadiazole derivatives as selective antitumor and radical scavenging agents. 61
30071406 2018
760
Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c. 61
29751044 2018
761
Proteomic analysis reveals that pheophorbide a-mediated photodynamic treatment inhibits prostate cancer growth by hampering GDP-GTP exchange of ras-family proteins. 61
29800714 2018
762
Mesenchymal stem cells up-regulate the invasive potential of prostate cancer cells via the eotaxin-3/CCR3 axis. 61
30029937 2018
763
Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors. 61
30082676 2018
764
Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest. 61
29767250 2018
765
Cytotoxic effect of Kalanchoe flammea and induction of intrinsic mitochondrial apoptotic signaling in prostate cancer cells. 61
29730133 2018
766
New phenophospholipids equipped with multi-functionalities: Regiospecific synthesis and characterization. 61
29621644 2018
767
PepSAVI-MS reveals anticancer and antifungal cycloviolacins in Viola odorata. 61
29734037 2018
768
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins. 61
30096958 2018
769
A Tumor Vascular-Targeted Interlocking Trimodal Nanosystem That Induces and Exploits Hypoxia. 61
30128230 2018
770
Anti-prostate cancer activity of 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide copper complexes in vivo by bioluminescence imaging. 61
30006867 2018
771
Autophagy inhibition improves the chemotherapeutic efficacy of cruciferous vegetable-derived diindolymethane in a murine prostate cancer xenograft model. 61
29607466 2018
772
Salinomycin-induced autophagy blocks apoptosis via the ATG3/AKT/mTOR signaling axis in PC-3 cells. 61
29966607 2018
773
Nontoxic Glucomoringin-Isothiocyanate (GMG-ITC) Rich Soluble Extract Induces Apoptosis and Inhibits Proliferation of Human Prostate Adenocarcinoma Cells (PC-3). 61
30150582 2018
774
Application of Mixture Design Response Surface Methodology for Combination Chemotherapy in PC-3 Human Prostate Cancer Cells. 61
29884690 2018
775
Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells. 61
30220968 2018
776
Synthesis, pharmacological evaluation and docking studies of progesterone and testosterone derivatives as anticancer agents. 61
29772243 2018
777
Design, synthesis and biological evaluation of AKT inhibitors bearing a piperidin-4-yl appendant. 61
30151089 2018
778
NOVEL CELLULAR STAINING PROTOCOL AND ANTIPROLIFERATIVE EFFECT OF VERNONIA AMYGDALINA DELILE ON LUNG AND PROSTATE CANCER CELLS. 61
30246001 2018
779
MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1. 61
29963147 2018
780
CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells. 61
30058677 2018
781
Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53. 61
30058678 2018
782
Cyclooxygenase-2 induces angiogenesis in pancreatic cancer mediated by prostaglandin E2. 61
29963167 2018
783
Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC1-Receptors concomitantly overexpressed on various malignancies - Is the concept feasible? 61
29864700 2018
784
High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways. 61
29749439 2018
785
Impact of Green Tea Catechin ECG and Its Synthesized Fluorinated Analogue on Prostate Cancer Cells and Stimulated Immunocompetent Cells. 61
29466808 2018
786
The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial-to-mesenchymal transition. 61
28383825 2018
787
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. 61
29718095 2018
788
Design, synthesis and biological evaluation of benzimidazole-rhodanine conjugates as potent topoisomerase II inhibitors. 61
30109008 2018
789
Asperindoles A⁻D and a p-Terphenyl Derivative from the Ascidian-Derived Fungus Aspergillus sp. KMM 4676. 61
29987238 2018
790
Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway. 61
29678660 2018
791
Optimized synthesis and antiproliferative activity of desTHPdactylolides. 61
29784275 2018
792
Aniline-Tetramic Acids from the Deep-Sea-Derived Fungus Cladosporium sphaerospermum L3P3 Cultured with the HDAC Inhibitor SAHA. 61
29985604 2018
793
Valproic acid induces three novel cytotoxic secondary metabolites in Diaporthe sp., an endophytic fungus from Datura inoxia Mill. 61
29759727 2018
794
Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide. 61
29412022 2018
795
DUSP1 is involved in the progression of small cell carcinoma of the prostate. 61
30108432 2018
796
Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer. 61
29929115 2018
797
Cytotoxic diterpene quinones from Salvia tebesana Bunge. 61
29772301 2018
798
Triterpenoids from Ziziphus jujuba induce apoptotic cell death in human cancer cells through mitochondrial reactive oxygen species production. 61
29968885 2018
799
The ethanol extraction of prepared Psoralea corylifolia induces apoptosis and autophagy and alteres genes expression assayed by cDNA microarray in human prostate cancer PC-3 cells. 61
29667321 2018
800
Mycobacterial inactivation protein extraction protocol for matrix-assisted laser desorption ionization time-of-flight characterization of clinical isolates. 61
30198499 2018
801
Chemical constituents of the fermentative extracts of marine fungi Phoma sp. CZD-F11 and Aspergillus sp. CZD-F18 from Zhoushan Archipelago, China. 61
29082752 2018
802
Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity. 61
29800498 2018
803
4-Fluorobenzaldehyde limonene-based thiosemicarbazone induces apoptosis in PC-3 human prostate cancer cells. 61
29674122 2018
804
Nicotinamide N-methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1. 61
29805651 2018
805
Frosted Slides Decorated with Silica Nanowires for Detecting Circulating Tumor Cells from Prostate Cancer Patients. 61
29770688 2018
806
A screening of growth inhibitory activity of Iranian medicinal plants on prostate cancer cell lines. 61
29806586 2018
807
Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. 61
29898731 2018
808
[Inhibitory effect of Qilan Capsules on the expressions of vasculogenic mimicry-related proteins in prostate cancer]. 61
30173460 2018
809
Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling. 61
29899325 2018
810
Lower endogenous p53 levels and degradation of AKT protein contribute to potent suppression of the new antibiotic Xiakemycin A on tumor cells. 61
29693151 2018
811
Siamese Crocodile White Blood Cell Extract Inhibits Cell Proliferation and Promotes Autophagy in Multiple Cancer Cell Lines. 61
29847866 2018
812
Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism. 61
29803995 2018
813
CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/mTOR pathway in vitro and in vivo. 61
29566977 2018
814
Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics. 61
29867083 2018
815
Cytotoxic Activity and Structure-Activity Relationship of Triazole-Containing Bis(Aryl Ether) Macrocycles. 61
29771004 2018
816
Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors. 61
29954109 2018
817
Polyprenylated polycyclic acylphloroglucinol: Angiogenesis inhibitor from Garcinia multiflora. 61
29655982 2018
818
Chiral resolution and anticancer effect of xanthones from Garcinia paucinervis. 61
29474978 2018
819
Synthesis and biological evaluation of estrone 3-O-ether derivatives containing the piperazine moiety. 61
29476759 2018
820
Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma. 61
29988965 2018
821
Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E. 61
29916747 2018
822
The Use of Human, Bovine, and Camel Milk Albumins in Anticancer Complexes with Oleic Acid. 61
29691701 2018
823
Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity. 61
29667768 2018
824
Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer. 61
29626645 2018
825
Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy. 61
29684274 2018
826
Chalcomoracin is a potent anticancer agent acting through triggering Oxidative stress via a mitophagy- and paraptosis-dependent mechanism. 61
29934599 2018
827
Design, synthesis, and antitumor evaluation of quinoline-imidazole derivatives. 61
29732607 2018
828
Long noncoding RNA BDNF-AS is associated with clinical outcomes and has functional role in human prostate cancer. 61
29710528 2018
829
A novel Tc-99m and fluorescence-labeled arginine-arginine-leucine-containing peptide as a multimodal tumor imaging agent in a murine tumor model. 61
29603784 2018
830
Biological evaluation of water soluble arene Ru(II) enantiomers with amino-oxime ligands. 61
29529470 2018
831
Hapalindole H Induces Apoptosis as an Inhibitor of NF-ĸB and Affects the Intrinsic Mitochondrial Pathway in PC-3 Androgen-insensitive Prostate Cancer Cells. 61
29848677 2018
832
MicroRNA-206 regulates the epithelial-mesenchymal transition and inhibits the invasion and metastasis of prostate cancer cells by targeting Annexin A2. 61
29805562 2018
833
Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity. 61
30108986 2018
834
(-)-Shikimic Acid as a Chiral Building Block for the Synthesis of New Cytotoxic 6-Aza-Analogues of Angucyclinones. 61
29895756 2018
835
Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors. 61
29775935 2018
836
α-Viniferin activates autophagic apoptosis and cell death by reducing glucocorticoid receptor expression in castration-resistant prostate cancer cells. 61
29904891 2018
837
7-Farnesyloxycoumarin Exerts Anti-cancer Effects on a Prostate Cancer Cell Line by 15-LOX-1 Inhibition. 61
29940744 2018
838
Cytotoxic Drimane Sesquiterpenoids Isolated from Perenniporia maackiae. 61
29878761 2018
839
The pharmacological properties of Ophiocordyceps xuefengensis revealed by transcriptome analysis. 61
29481852 2018
840
Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. 61
29633510 2018
841
Prostate Cancer Cell-Specific Cytotoxicity of Sub-Micron Potassium Niobate Powder. 61
29442813 2018
842
Long non-coding RNA CCAT1 promotes the migration and invasion of prostate cancer PC-3 cells. 61
29863242 2018
843
A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2. 61
29805743 2018
844
Synthesis, biological evaluation and molecular docking study of 1-amino-2-aroylnaphthalenes against prostate cancer. 61
29606573 2018
845
Novel 64Cu Labeled RGD2-BBN Heterotrimers for PET Imaging of Prostate Cancer. 61
29587479 2018
846
Subcellular localization of aquaporin 3 in prostate cancer is regulated by RalA. 61
29532894 2018
847
MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11. 61
29542173 2018
848
Camel milk attenuates methotrexate-induced kidney injury via activation of PI3K/Akt/eNOS signaling and intervention with oxidative aberrations. 61
29667662 2018
849
Femoral rotational asymmetry is a common anatomical variant. 61
29359478 2018
850
Theranostic Pt(IV) Conjugate with Target Selectivity for Androgen Receptor. 61
29667815 2018
851
Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents. 61
29635165 2018
852
Ajmaline, Oxindole, and Cytotoxic Macroline-Akuammiline Bisindole Alkaloids from Alstonia penangiana. 61
29746134 2018
853
Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8+ T-cells Derived from Patients with Metastatic Castrate-resistant Disease. 61
29275833 2018
854
Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin. 61
29664606 2018
855
Synthesis, biological evaluation and SAR of naftopidil-based arylpiperazine derivatives. 61
29615343 2018
856
Microwave-assisted one-pot synthesis of new phenanthrene fused-tetrahydrodibenzo-acridinones as potential cytotoxic and apoptosis inducing agents. 61
29609122 2018
857
[Retracted] Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo. 61
29436677 2018
858
Sulfamic acid promoted one-pot synthesis of phenanthrene fused-dihydrodibenzo-quinolinones: Anticancer activity, tubulin polymerization inhibition and apoptosis inducing studies. 61
29525336 2018
859
Loss of scinderin decreased expression of epidermal growth factor receptor and promoted apoptosis of castration-resistant prostate cancer cells. 61
29744289 2018
860
Water soluble glucose derivative of thiocarbohydrazone acts as ionophore with cytotoxic effects on tumor cells. 61
29452884 2018
861
Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells. 61
29119376 2018
862
Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion. 61
29524043 2018
863
A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo. 61
29669200 2018
864
Structure-activity relationships of succinimidyl-Cys-C(O)-Glu derivatives with different near-infrared fluorophores as optical imaging probes for prostate-specific membrane antigen. 61
29580851 2018
865
Extraction, profiling and bioactivity analysis of volatile glucosinolates present in oil extract of Brassica juncea var. raya. 61
29692548 2018
866
p62 as a therapeutic target for inhibition of autophagy in prostate cancer. 61
29368435 2018
867
Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells. 61
29599322 2018
868
Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation. 61
29444261 2018
869
Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer. 61
29455003 2018
870
GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling. 61
29431615 2018
871
Prazosin but Not Tamsulosin Sensitises PC-3 and LNCaP Prostate Cancer Cells to Docetaxel. 61
29669348 2018
872
MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG. 61
28551819 2018
873
LTBP3 promotes early metastatic events during cancer cell dissemination. 61
29348457 2018
874
Design, synthesis and anticancer studies of novel aminobenzazolyl pyrimidines as tyrosine kinase inhibitors. 61
29342447 2018
875
Integrin αVβ3-targeted SPECT/CT for the assessment of Bevacizumab therapy in orthotopic lung cancer xenografts. 61
29541186 2018
876
Bioactive Indolocarbazoles from the Marine-Derived Streptomyces sp. DT-A61. 61
29558119 2018
877
Three new elemanolides from the seeds of Vernonia anthelmintica. 61
28675942 2018
878
A novel Salvialactomine from the callus culture of Salvia santolinifolia Boiss. 61
28412869 2018
879
Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation. 61
29524728 2018
880
Multiple protective effect of peptides released from Olea europaea and Prunus persica seeds against oxidative damage and cancer cell proliferation. 61
29579948 2018
881
A Bowman-Birk type chymotrypsin inhibitor peptide from the amphibian, Hylarana erythraea. 61
29643444 2018
882
Synthesis, Radiolabelling and In Vitro Imaging of Multifunctional Nanoceramics. 61
29938196 2018
883
New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation. 61
29517903 2018
884
Effect of quercetin glucosides from Allium extracts on HepG2, PC-3 and HT-29 cancer cell lines. 61
29552109 2018
885
MiRNALet-7a mediates prostate cancer PC-3 cell invasion, migration by inducing epithelial-mesenchymal transition through CCR7/MAPK pathway. 61
29236328 2018
886
Electrical Impedance Measurements of Biological Cells in Response to External Stimuli. 61
29402081 2018
887
Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. 61
29653561 2018
888
Cytotoxic protobassic acid saponins from the kernels of Palaquium formosanum. 61
29567224 2018
889
Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression. 61
29155210 2018
890
JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice. 61
29248440 2018
891
MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway. 61
29353209 2018
892
[Over-expression of miR-151a-3p inhibits proliferation and migration of PC-3 prostate cancer cells]. 61
29773107 2018
893
Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer. 61
29745091 2018
894
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion. 61
29271400 2018
895
Testosterone metabolites inhibit proliferation of castration- and therapy-resistant prostate cancer. 61
29682196 2018
896
Establishment and characterization of two cabazitaxel-resistant prostate cancer cell lines. 61
29662635 2018
897
NAC1 promotes the migration of prostate cancer cells and participates in osteoclastogenesis by negatively regulating IFNβ. 61
29435019 2018
898
Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells. 61
29164633 2018
899
Green Synthesis of Carbon Dots Derived from Walnut Oil and an Investigation of Their Cytotoxic and Apoptogenic Activities toward Cancer Cells. 61
29670850 2018
900
Androgen receptor (AR) degradation enhancer ASC-J9® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth. 61
29203251 2018
901
Synthesis and properties of N-methylimidazole solvates of vanadium(ii), chromium(ii) and iron(ii) phthalocyanines. Strong NIR absorption in VII(MeIm)2(Pc2-). 61
29528080 2018
902
Synthesis and cytotoxic effect of pregnenolone derivatives with one or two α,β-unsaturated carbonyls and an ester moiety at C-21 or C-3. 61
29360536 2018
903
Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway. 61
29328471 2018
904
Synthesis and Antiproliferative Activity of Minor Hops Prenylflavonoids and New Insights on Prenyl Group Cyclization. 61
29597299 2018
905
The 5T4 oncofetal glycoprotein does not act as a general organizer of the CXCL12 system in cancer cells. 61
29408206 2018
906
Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4. 61
29269867 2018
907
Identification of N-arylsulfonylpyrimidones as anticancer agents. 61
29332183 2018
908
Bacillus amyloliquefaciens induces production of a novel blennolide K in coculture of Setophoma terrestris. 61
29288594 2018
909
Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer. 61
29554906 2018
910
Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status. 61
29499113 2018
911
Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism. 61
29435052 2018
912
Curcumin inspired 2-chloro/phenoxy quinoline analogues: Synthesis and biological evaluation as potential anticancer agents. 61
29429834 2018
913
Monomeric and Dimeric 68Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs). 61
29432691 2018
914
Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile. 61
29400475 2018
915
Activation of estrogen receptor beta (ERβ) regulates the expression of N-cadherin, E-cadherin and β-catenin in androgen-independent prostate cancer cells. 61
29341930 2018
916
Engineering of the Trichoderma reesei xylanase3 promoter for efficient enzyme expression. 61
29417196 2018
917
Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation. 61
29531259 2018
918
Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents. 61
29310026 2018
919
Maspin Enhances the Anticancer Activity of Curcumin in Hormone-refractory Prostate Cancer Cells. 61
29374713 2018
920
Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics. 61
29407983 2018
921
Oxibendazole inhibits prostate cancer cell growth. 61
29434928 2018
922
Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c-met. 61
29434932 2018
923
Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype. 61
29472531 2018
924
Synthesis of gold(I) phosphine complexes containing the 2-BrC6F4PPh2 ligand: Evaluation of anticancer activity in 2D and 3D spheroidal models of HeLa cancer cells. 61
29331752 2018
925
Development and formulation of Moringa oleifera standardised leaf extract film dressing for wound healing application. 61
29080829 2018
926
Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy. 61
29406710 2018
927
Structurally Diverse Cytotoxic Dimeric Chalcones from Oxytropis chiliophylla. 61
29400468 2018
928
Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN7-14 and Antagonist RM26. 61
29254329 2018
929
Synthesis and biological evaluation of novel bavachinin analogs as anticancer agents. 61
29335212 2018
930
Ultrasensitive electrochemical immunosensing of tumor suppressor protein p53 in unprocessed human plasma and cell lysates using a novel nanocomposite based on poly-cysteine/graphene quantum dots/gold nanoparticle. 61
29113888 2018
931
Dietary Glycation Products Regulate Immune Homeostasis: Early Glycation Products Promote Prostate Cancer Cell Proliferation through Modulating Macrophages. 61
29082675 2018
932
Design, synthesis and evaluation of novel N-hydroxybenzamides/N-hydroxypropenamides incorporating quinazolin-4(3H)-ones as histone deacetylase inhibitors and antitumor agents. 61
29223029 2018
933
Sarcosine influences apoptosis and growth of prostate cells via cell-type specific regulation of distinct sets of genes. 61
29105933 2018
934
Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis. 61
29174801 2018
935